Qiagen NV
Buy, Hold or Sell?

Let's analyse Qiagen together

Penke I guess you are interested in Qiagen NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Qiagen NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Qiagen NV

I send you an email if I find something interesting about Qiagen NV.

Quick analysis of Qiagen (30 sec.)

What can you expect buying and holding a share of Qiagen? (30 sec.)

How much money do you get?

$0.00

When do you have the money?

1 year

How often do you get paid?

32.5%

What is your share worth?

Current worth

$17.01

Expected worth in 1 year

$18.98

How sure are you?

72.5%

+ What do you gain per year?

Total Gains per Share

$1.96

Return On Investment

4.7%

For what price can you sell your share?

Current Price per Share

$41.89

Expected price per share

$35.58 - $45.38

How sure are you?

50%

1. Valuation of Qiagen (5 min.)

Live pricePrice per Share (EOD)

$41.89

Book Value per Share

$17.01

Intrinsic Value Per Share

$-11.45 - $20.74

Total Value Per Share

$5.56 - $37.75

My calculation of the intrinsic value of Qiagen is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.27) 3Y: ($0.47) TTM: ($0.33)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($0.01) 3Y: ($-0.04) TTM: ($0.03)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$0.71	$1.91	$0.53 - $1.99
2	$0.88	$3.87	$-0.04 - $2.10
3	$0.55	$5.88	$-0.60 - $2.20
4	$-0.22	$7.92	$-1.16 - $2.31
5	$-1.37	$9.99	$-1.72 - $2.42
6	$-2.87	$12.09	$-2.29 - $2.52
7	$-4.66	$14.22	$-2.85 - $2.63
8	$-6.71	$16.38	$-3.41 - $2.74
9	$-8.98	$18.55	$-3.97 - $2.84
10	$-11.45	$20.74	$-4.53 - $2.95

2. Growth of Qiagen (5 min.)

Is Qiagen growing?

	Current year	Previous year	Grow	Grow %
How rich?	$3.8b	$3.3b	$342.3m	9.3%

How much money is Qiagen making?

	Current year	Previous year	Grow	Grow %
Making money	$85.3m	$105.8m	-$20.4m	-24.0%
Net Profit Margin	17.3%	19.4%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Qiagen (5 min.)

4. Comparing to competitors in the Diagnostics & Research industry (5 min.)

Industry Rankings (Diagnostics & Research)

Richest
#15 / 145

Most Revenue
#33 / 145

Most Profit
#26 / 145

Most Efficient
#26 / 145

What can you expect buying and holding a share of Qiagen? (5 min.)

Welcome investor! Qiagen's management wants to use your money to grow the business. In return you get a share of Qiagen.

What can you expect buying and holding a share of Qiagen?

First you should know what it really means to hold a share of Qiagen. And how you can make/lose money.

Speculation

The Price per Share of Qiagen is $41.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Qiagen.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Qiagen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $17.01. Based on the TTM, the Book Value Change Per Share is $0.49 per quarter. Based on the YOY, the Book Value Change Per Share is $0.42 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Qiagen.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	0.44	1.0%	0.38	0.9%	0.63	1.5%	0.38	0.9%	0.25	0.6%
Usd Book Value Change Per Share	0.50	1.2%	0.49	1.2%	0.42	1.0%	0.28	0.7%	0.14	0.3%
Usd Dividend Per Share	0.00	0.0%	0.00	0.0%	0.40	0.9%	0.20	0.5%	0.36	0.9%
Usd Total Gains Per Share	0.50	1.2%	0.49	1.2%	0.82	2.0%	0.48	1.1%	0.49	1.2%
Usd Price Per Share	43.43	-	43.72	-	46.84	-	45.20	-	36.62	-
Price to Earnings Ratio	24.88	-	29.24	-	21.74	-	37.34	-	43.96	-
Price-to-Total Gains Ratio	86.83	-	107.39	-	103.82	-	80.34	-	-55.68	-
Price to Book Ratio	2.55	-	2.67	-	3.24	-	3.50	-	3.02	-
Price-to-Total Gains Ratio	86.83	-	107.39	-	103.82	-	80.34	-	-55.68	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	41.89
Number of shares	23

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.00	0.20
Usd Book Value Change Per Share	0.49	0.28
Usd Total Gains Per Share	0.49	0.48
Gains per Quarter (23 shares)	11.29	11.06
Gains per Year (23 shares)	45.16	44.25

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	0	45	35	18	26	34
2	0	90	80	36	52	78
3	0	135	125	54	78	122
4	0	181	170	73	104	166
5	0	226	215	91	130	210
6	0	271	260	109	157	254
7	0	316	305	127	183	298
8	0	361	350	145	209	342
9	0	406	395	163	235	386
10	0	452	440	182	261	430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	19.0	1.0	0.0	95.0%	38.0	2.0	0.0	95.0%	97.0	4.0	0.0	96.0%
Book Value Change Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	16.0	4.0	0.0	80.0%	26.0	14.0	0.0	65.0%	74.0	23.0	4.0	73.3%
Dividend per Share	0.0	0.0	4.0	0.0%	3.0	0.0	9.0	25.0%	5.0	0.0	15.0	25.0%	13.0	0.0	27.0	32.5%	13.0	0.0	88.0	12.9%
Total Gains per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	17.0	3.0	0.0	85.0%	29.0	11.0	0.0	72.5%	77.0	20.0	4.0	76.2%

Fundamentals of Qiagen

About Qiagen NV

https://www.qiagen.com
Diagnostics & Research
5191
Hulsterweg 82, Venlo, Netherlands, 5912 PL
Google Maps Bing Maps

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Fundamental data was last updated by Penke on 2024-04-04 23:21:05.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Qiagen NV.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Qiagen earns for each $1 of revenue.

Above 10% is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
A Net Profit Margin of 19.2% means that $0.19 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Qiagen NV:

The MRQ is 19.2%. The company is making a huge profit. +2
The TTM is 17.3%. The company is making a huge profit. +2

Trends

Current period		Compared to		+/-
MRQ	19.2%	TTM	17.3%	+1.8%
TTM	17.3%	YOY	19.4%	-2.1%
TTM	17.3%	5Y	15.0%	+2.4%
5Y	15.0%	10Y	11.5%	+3.5%

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	19.2%	-7.7%	+26.9%
TTM	17.3%	-6.7%	+24.0%
YOY	19.4%	2.4%	+17.0%
5Y	15.0%	-1.5%	+16.5%
10Y	11.5%	-3.4%	+14.9%

Measures how much net profit Qiagen earns for each $1 of revenue.

Revenue is the amount of profit Qiagen generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Qiagen earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
Can be used to compare companies within the Diagnostics & Research industry.

You typically want a high profit margin. This means that for each $1 in sales, Qiagen makes more profit. This shows the investor how efficiently Qiagen is operating in general and compared to other companies in the same industry. Qiagen operates in the Diagnostics & Research industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Qiagen. If profit margins remain low (compared to the Diagnostics & Research industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Qiagen is 0.19. This means that Qiagen earned $0.19 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Diagnostics & Research industry is -7.7%.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Qiagen with other companies in the same industry (Diagnostics & Research).
Net profit margin should rise over the years.
Can be influenced when Qiagen sells assets (profit will increase while costs remain the same).
It won’t show what part of Qiagen is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Qiagen

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Qiagen = 97,664
Total revenue MRQ Qiagen = 509,162
$97,664 / $509,162 = 0.19 or 19.2%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Qiagen is using its assets to generate profit.

Above 5% is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
1.6% Return on Assets means that Qiagen generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Qiagen NV:

The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
The TTM is 1.4%. Using its assets, the company is less efficient in making profit.

Trends

Current period		Compared to		+/-
MRQ	1.6%	TTM	1.4%	+0.2%
TTM	1.4%	YOY	1.7%	-0.3%
TTM	1.4%	5Y	1.3%	+0.1%
5Y	1.3%	10Y	1.0%	+0.4%

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	1.6%	-1.7%	+3.3%
TTM	1.4%	-1.3%	+2.7%
YOY	1.7%	-0.9%	+2.6%
5Y	1.3%	-0.5%	+1.8%
10Y	1.0%	-0.9%	+1.9%

Shows how efficient Qiagen is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Qiagen is using its resources to generate profit. If the return on assets (1.6%) from Qiagen are higher than the Diagnostics & Research mean (-1.7%) that means Qiagen is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Qiagen is 1.6%. This means the company generated $0.02 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Diagnostics & Research industry is -1.7%.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Qiagen

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Qiagen = 97,664
Total assets MRQ (balance sheet) from Qiagen = 6,115,190
97,664 / 6,115,190 = 0.02 or 1.6%

ROA is an important ratio as it will tell you how effectively Qiagen is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Qiagen is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
2.6% Return on Equity means Qiagen generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Qiagen NV:

The MRQ is 2.6%. Using its investors money, the company is inefficient in making profit. -1
The TTM is 2.3%. Using its investors money, the company is inefficient in making profit. -1

Trends

Current period		Compared to		+/-
MRQ	2.6%	TTM	2.3%	+0.2%
TTM	2.3%	YOY	3.2%	-0.9%
TTM	2.3%	5Y	2.6%	-0.3%
5Y	2.6%	10Y	1.8%	+0.8%

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	2.6%	-0.7%	+3.3%
TTM	2.3%	-0.1%	+2.4%
YOY	3.2%	0.3%	+2.9%
5Y	2.6%	-1.4%	+4.0%
10Y	1.8%	-2.3%	+4.1%

Shows how efficient Qiagen is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Diagnostics & Research industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Qiagen is 2.6%. This means Qiagen generated $0.03 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Diagnostics & Research industry is -0.7%.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if Qiagen existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Qiagen

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Qiagen = 97,664
Shareholders equity (balance sheet) MRQ Qiagen = 3,807,764
97,664 / 3,807,764 = 0.03 or 2.6%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Qiagen NV.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Qiagen is operating .

Measures how much profit Qiagen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
An Operating Margin of 26.4% means the company generated $0.26 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Qiagen NV:

The MRQ is 26.4%. The company is operating very efficient. +2
The TTM is 26.0%. The company is operating very efficient. +2

Trends

Current period		Compared to		+/-
MRQ	26.4%	TTM	26.0%	+0.4%
TTM	26.0%	YOY	26.3%	-0.3%
TTM	26.0%	5Y	27.3%	-1.3%
5Y	27.3%	10Y	19.9%	+7.4%

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	26.4%	-6.2%	+32.6%
TTM	26.0%	0.5%	+25.5%
YOY	26.3%	4.3%	+22.0%
5Y	27.3%	3.7%	+23.6%
10Y	19.9%	-1.3%	+21.2%

Measures how efficient Qiagen is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Qiagen is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Qiagen is 26.4%. This means that Qiagen earned $0.26 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Diagnostics & Research industry is -6.2%.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Qiagen

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Qiagen = 134,490
Total revenue MRQ Qiagen = 509,162
$134,490 / $509,162 = 0.26 or 26.4%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Qiagen is keeping operating costs low.

Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
An Operation Ratio of 0.74 means that the operating costs are $0.74 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Qiagen NV:

The MRQ is 0.736. The company is efficient in keeping operating costs low. +1
The TTM is 0.767. The company is efficient in keeping operating costs low. +1

Trends

Current period		Compared to		+/-
MRQ	0.736	TTM	0.767	-0.031
TTM	0.767	YOY	0.735	+0.032
TTM	0.767	5Y	0.747	+0.020
5Y	0.747	10Y	0.812	-0.065

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	0.736	1.296	-0.560
TTM	0.767	1.301	-0.534
YOY	0.735	1.238	-0.503
5Y	0.747	1.268	-0.521
10Y	0.812	1.217	-0.405

Measures how efficient Qiagen is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Qiagen is 73.6%. This means that Qiagen earned $0.74 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Diagnostics & Research industry is 1.30.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Qiagen

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(164,018 +210,654) \ 509,162 = 0.74

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Qiagen NV.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Qiagen is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
A Current Ratio of 1.99 means the company has $1.99 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Qiagen NV:

The MRQ is 1.990. The company is able to pay all its short-term debts. +1
The TTM is 2.656. The company is able to pay all its short-term debts. +1

Trends

Current period		Compared to		+/-
MRQ	1.990	TTM	2.656	-0.666
TTM	2.656	YOY	2.179	+0.477
TTM	2.656	5Y	2.227	+0.429
5Y	2.227	10Y	2.771	-0.545

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	1.990	2.111	-0.121
TTM	2.656	2.298	+0.358
YOY	2.179	2.581	-0.402
5Y	2.227	3.012	-0.785
10Y	2.771	3.081	-0.310

Measures if Qiagen is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Qiagen if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Qiagen is 1.99. This means Qiagen has $1.99 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Diagnostics & Research industry is 2.11.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Qiagen

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
2,147,560 \ 1,079,293) = 1.99

The current ratio measures if Qiagen is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Qiagen is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Qiagen does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Qiagen is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Qiagen is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
A Quick Ratio of 1.82 means the company can pay off $1.82 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Qiagen NV:

The MRQ is 1.819. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 2.619. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	1.819	TTM	2.619	-0.800
TTM	2.619	YOY	2.215	+0.403
TTM	2.619	5Y	1.952	+0.667
5Y	1.952	10Y	2.476	-0.524

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	1.819	1.204	+0.615
TTM	2.619	1.285	+1.334
YOY	2.215	1.565	+0.650
5Y	1.952	1.925	+0.027
10Y	2.476	2.128	+0.348

1.4. Solvency of Qiagen NV.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Qiagen assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Qiagen to Diagnostics & Research industry mean.
A Debt to Asset Ratio of 0.38 means that Qiagen assets are financed with 37.7% credit (debt) and the remaining percentage (100% - 37.7%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Qiagen NV:

The MRQ is 0.377. The company is very able to pay all its debts by selling its assets. +2
The TTM is 0.403. The company is very able to pay all its debts by selling its assets. +2

Trends

Current period		Compared to		+/-
MRQ	0.377	TTM	0.403	-0.026
TTM	0.403	YOY	0.470	-0.067
TTM	0.403	5Y	0.485	-0.081
5Y	0.485	10Y	0.457	+0.028

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	0.377	0.421	-0.044
TTM	0.403	0.407	-0.004
YOY	0.470	0.394	+0.076
5Y	0.485	0.448	+0.037
10Y	0.457	0.446	+0.011

Measures how much % of Qiagen assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Qiagen than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Qiagen to Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Qiagen is 0.38. This means means that Qiagen is financed with 37.7% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Diagnostics & Research industry is 211.1%.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Qiagen has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Qiagen

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
2,307,426 \ 6,115,190 = 37.7% or 0.38.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Qiagen is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Qiagen to the Diagnostics & Research industry mean.
A Debt to Equity ratio of 60.6% means that company has $0.61 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Qiagen NV:

The MRQ is 0.606. The company is very able to pay all its debts with equity. +2
The TTM is 0.680. The company is very able to pay all its debts with equity. +2

Trends

Current period		Compared to		+/-
MRQ	0.606	TTM	0.680	-0.074
TTM	0.680	YOY	0.889	-0.209
TTM	0.680	5Y	0.959	-0.279
5Y	0.959	10Y	0.866	+0.093

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	0.606	0.606	0.000
TTM	0.680	0.567	+0.113
YOY	0.889	0.631	+0.258
5Y	0.959	0.658	+0.301
10Y	0.866	0.742	+0.124

Measures if Qiagen is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Qiagen is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Qiagen is 0.61. This means that Qiagen can pay off $0.61 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Diagnostics & Research industry is 0.61.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Qiagen

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
2,307,426 \ 3,807,764 = 0.61 or 60.6%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Qiagen NV

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Qiagen generates.

Above 15 is considered overpriced but always compare Qiagen to the Diagnostics & Research industry mean.
A PE ratio of 24.88 means the investor is paying $24.88 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Qiagen NV:

The EOD is 24.000. Based on the earnings, the company is fair priced.
The MRQ is 24.883. Based on the earnings, the company is fair priced.
The TTM is 29.235. Based on the earnings, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	24.000	MRQ	24.883	-0.882
MRQ	24.883	TTM	29.235	-4.352
TTM	29.235	YOY	21.736	+7.499
TTM	29.235	5Y	37.340	-8.105
5Y	37.340	10Y	43.958	-6.618

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
EOD	24.000	-0.261	+24.261
MRQ	24.883	-0.409	+25.292
TTM	29.235	-0.341	+29.576
YOY	21.736	0.002	+21.734
5Y	37.340	4.832	+32.508
10Y	43.958	5.198	+38.760

Measures how much money you pay for each share for every $1 in earnings Qiagen generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Qiagen to the Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Qiagen is 24.88. This means the investor is paying $24.88 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Diagnostics & Research industry is -0.41.
What is the trend?
The trend is important because it shows you how Qiagen is performing over time. The most recent quarter might be important if Qiagen released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Qiagen up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Qiagen

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 223,823 = EPS
PE ratio MRQ = 24.88

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Qiagen NV:

The EOD is 23.642. Based on how much money comes from the company's main activities, the company is underpriced. +1
The MRQ is 24.511. Based on how much money comes from the company's main activities, the company is underpriced. +1
The TTM is 39.887. Based on how much money comes from the company's main activities, the company is fair priced.

Trends

Current period		Compared to		+/-
EOD	23.642	MRQ	24.511	-0.869
MRQ	24.511	TTM	39.887	-15.376
TTM	39.887	YOY	21.669	+18.219
TTM	39.887	5Y	20.229	+19.658
5Y	20.229	10Y	29.578	-9.349

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
EOD	23.642	-0.291	+23.933
MRQ	24.511	-0.441	+24.952
TTM	39.887	-1.388	+41.275
YOY	21.669	-2.079	+23.748
5Y	20.229	-1.446	+21.675
10Y	29.578	-1.971	+31.549

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Qiagen is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
A PB ratio of 2.55 means the investor is paying $2.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Qiagen NV:

The EOD is 2.462. Based on the equity, the company is underpriced. +1
The MRQ is 2.553. Based on the equity, the company is underpriced. +1
The TTM is 2.667. Based on the equity, the company is underpriced. +1

Trends

Current period		Compared to		+/-
EOD	2.462	MRQ	2.553	-0.091
MRQ	2.553	TTM	2.667	-0.114
TTM	2.667	YOY	3.239	-0.571
TTM	2.667	5Y	3.504	-0.837
5Y	3.504	10Y	3.017	+0.487

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
EOD	2.462	1.857	+0.605
MRQ	2.553	2.228	+0.325
TTM	2.667	2.222	+0.445
YOY	3.239	3.104	+0.135
5Y	3.504	3.447	+0.057
10Y	3.017	4.036	-1.019

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Qiagen NV.

3.1. Institutions holding Qiagen NV

Institutions are holding 74.243% of the shares of Qiagen NV.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-09-30	Massachusetts Financial Services Company	9.7541	0.3156	22257083	1072923	5.0647
2023-09-30	Vanguard Group Inc	3.8268	0.0087	8732096	140063	1.6301
2023-09-30	BlackRock Inc	3.2834	0.0087	7492120	-51117	-0.6777
2023-09-30	Wellington Management Company LLP	2.6532	0.0491	6054116	2709030	80.9854
2023-09-30	Amundi	2.5811	0.1113	5889712	-16596	-0.281
2023-09-30	Fidelity International Ltd	2.0594	0.2239	4699175	202400	4.501
2023-09-30	Point72 Asset Management, L.P.	1.919	0.5174	4378719	4378418	1454623.9203
2023-09-30	DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main	1.5145	0.1989	3455795	-157004	-4.3458
2023-09-30	DekaBank Deutsche Girozentrale	1.4836	0.3145	3385274	77409	2.3401
2023-09-30	Deutsche Bank AG	1.4667	0.0875	3346676	-1382939	-29.24
2023-09-30	Morgan Stanley - Brokerage Accounts	1.3278	0.0125	3029825	121155	4.1653
2023-09-30	Bank of America Corp	1.3087	0.0133	2986272	603556	25.3306
2023-09-30	State Street Corporation	0.9693	0.005	2211778	11768	0.5349
2023-09-30	Millennium Management LLC	0.8933	0.0417	2038245	82640	4.2258
2023-09-30	Legal & General Group PLC	0.8867	0.0286	2023372	-33476	-1.6275
2023-09-30	BNP Paribas Arbitrage, SA	0.7278	0.0864	1660779	576571	53.179
2023-09-30	Earnest Partners LLC	0.6624	0.3531	1511503	104069	7.3942
2023-09-30	Southpoint Capital Advisors LP	0.6574	1.3563	1500000	500000	50
2023-09-30	Neuberger Berman Group LLC	0.6351	0.0534	1449072	-47549	-3.1771
2023-09-30	Goldman Sachs Group Inc	0.6097	0.0113	1391190	-1707653	-55.1061
Total		39.22	3.7972	89492802	+7183668	+8.0%

3.2. Funds holding Qiagen NV

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2024-02-29	MFS International Equity R6	1.7772	0.8869	3933855	183576	4.895
2023-12-31	MFS International Research Equity	1.6616	1.0115	3791796	-94767	-2.4383
2023-12-31	MFS International Equity	1.6522	0.9487	3770477	279034	7.9919
2024-02-29	MFS Research International I	1.6337	0.9527	3616279	81005	2.2913
2024-02-29	MFS International Growth A	1.5256	0.898	3376999	51582	1.5511
2024-02-29	Vanguard Total Intl Stock Index Inv	1.3232	0.03	2929004	97434	3.441
2024-02-29	iShares TecDAX® ETF (DE)	0.823	9.364	1821856	0	0
2023-06-30	DekaFonds CF	0.7866	1.4552	1794944	960000	114.9778
2024-02-29	Vanguard Developed Markets Index Admiral	0.7907	0.0403	1750208	63044	3.7367
2023-12-31	Vanguard Capital Opportunity Inv	0.6663	0.3145	1520507	0	0
2024-02-29	Vanguard Instl Ttl Intl Stk Mkt Idx TrII	0.6387	0.0305	1413725	51741	3.7989
2024-02-29	State St Russell Sm/Mid Cp® Indx NL Cl C	0.5974	0.1355	1322413	39672	3.0928
2024-02-29	Allspring Special Mid Cap Value Inst	0.5911	0.438	1308515	104633	8.6913
2023-11-30	BGF World Healthscience A2	0.5698	0.4174	1300247	95420	7.9198
2024-02-29	MFS International Equity CIT -Cl4	0.5735	0.895	1269576	20724	1.6594
2024-02-29	iShares Core MSCI EAFE ETF	0.5732	0.0497	1268728	0	0
2024-02-29	EARNEST Partners Smid Cap Core Founders	0.562	1.5412	1244002	38824	3.2214
2023-12-31	Wellington Strategic Eurp Eq EUR S Ac	0.5126	2.3688	1169801	39460	3.491
2024-02-29	iShares MSCI EAFE Min Vol Factor ETF	0.523	0.6937	1157804	7074	0.6147
2024-02-29	Folksam LO Världen	0.4969	0.6761	1100000	65010	6.2812
Total		18.2783	23.1477	40860736	+2083466	+5.1%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Qiagen NV compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	0.500	0.491	+2%	0.422	+18%	0.284	+76%	0.136	+268%
Book Value Per Share	-	-	17.012	16.413	+4%	14.466	+18%	13.165	+29%	12.143	+40%
Current Ratio	-	-	1.990	2.656	-25%	2.179	-9%	2.227	-11%	2.771	-28%
Debt To Asset Ratio	-	-	0.377	0.403	-6%	0.470	-20%	0.485	-22%	0.457	-17%
Debt To Equity Ratio	-	-	0.606	0.680	-11%	0.889	-32%	0.959	-37%	0.866	-30%
Dividend Per Share	-	-	-	-	0%	0.395	-100%	0.197	-100%	0.357	-100%
Eps	-	-	0.436	0.377	+16%	0.625	-30%	0.378	+16%	0.252	+73%
Free Cash Flow Per Share	-	-	0.443	0.332	+34%	0.615	-28%	0.328	+35%	0.272	+63%
Free Cash Flow To Equity Per Share	-	-	0.410	-0.153	+137%	0.479	-14%	0.023	+1652%	0.192	+113%
Gross Profit Margin	-	-	-0.203	-0.356	+75%	-0.190	-6%	-0.545	+169%	-1.633	+705%
Intrinsic Value_10Y_max	-	-	20.740	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-11.449	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	1.914	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	0.714	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	5.876	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	0.545	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	9.989	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	-1.374	-	-	-	-	-	-	-	-
Market Cap	9272644394.880	-5%	9720615908.870	9780705170.728	-1%	10779220177.500	-10%	10414519900.646	-7%	8470104031.366	+15%
Net Profit Margin	-	-	0.192	0.173	+11%	0.194	-1%	0.150	+28%	0.115	+67%
Operating Margin	-	-	0.264	0.260	+2%	0.263	+0%	0.273	-3%	0.199	+32%
Operating Ratio	-	-	0.736	0.767	-4%	0.735	+0%	0.747	-1%	0.812	-9%
Pb Ratio	2.462	-4%	2.553	2.667	-4%	3.239	-21%	3.504	-27%	3.017	-15%
Pe Ratio	24.000	-4%	24.883	29.235	-15%	21.736	+14%	37.340	-33%	43.958	-43%
Price Per Share	41.890	-4%	43.430	43.723	-1%	46.838	-7%	45.205	-4%	36.616	+19%
Price To Free Cash Flow Ratio	23.642	-4%	24.511	39.887	-39%	21.669	+13%	20.229	+21%	29.578	-17%
Price To Total Gains Ratio	83.751	-4%	86.830	107.393	-19%	103.816	-16%	80.338	+8%	-55.677	+164%
Quick Ratio	-	-	1.819	2.619	-31%	2.215	-18%	1.952	-7%	2.476	-27%
Return On Assets	-	-	0.016	0.014	+15%	0.017	-5%	0.013	+21%	0.010	+67%
Return On Equity	-	-	0.026	0.023	+10%	0.032	-20%	0.026	-1%	0.018	+41%
Total Gains Per Share	-	-	0.500	0.491	+2%	0.817	-39%	0.481	+4%	0.493	+1%
Usd Book Value	-	-	3807764000.000	3671562000.000	+4%	3329230000.000	+14%	3024511700.000	+26%	2807025675.000	+36%
Usd Book Value Change Per Share	-	-	0.500	0.491	+2%	0.422	+18%	0.284	+76%	0.136	+268%
Usd Book Value Per Share	-	-	17.012	16.413	+4%	14.466	+18%	13.165	+29%	12.143	+40%
Usd Dividend Per Share	-	-	-	-	0%	0.395	-100%	0.197	-100%	0.357	-100%
Usd Eps	-	-	0.436	0.377	+16%	0.625	-30%	0.378	+16%	0.252	+73%
Usd Free Cash Flow	-	-	99146000.000	74163250.000	+34%	141482000.000	-30%	75228800.000	+32%	62858475.000	+58%
Usd Free Cash Flow Per Share	-	-	0.443	0.332	+34%	0.615	-28%	0.328	+35%	0.272	+63%
Usd Free Cash Flow To Equity Per Share	-	-	0.410	-0.153	+137%	0.479	-14%	0.023	+1652%	0.192	+113%
Usd Market Cap	9272644394.880	-5%	9720615908.870	9780705170.728	-1%	10779220177.500	-10%	10414519900.646	-7%	8470104031.366	+15%
Usd Price Per Share	41.890	-4%	43.430	43.723	-1%	46.838	-7%	45.205	-4%	36.616	+19%
Usd Profit	-	-	97664000.000	85325750.000	+14%	105802750.000	-8%	79742300.000	+22%	53690600.000	+82%
Usd Revenue	-	-	509162000.000	491327750.000	+4%	535379500.000	-5%	487762800.000	+4%	415959850.000	+22%
Usd Total Gains Per Share	-	-	0.500	0.491	+2%	0.817	-39%	0.481	+4%	0.493	+1%
	EOD	+4 -4	MRQ	TTM	+28 -6	YOY	+10 -26	5Y	+26 -10	10Y	+31 -5

4.2. Fundamental Score

Let's check the fundamental score of Qiagen NV based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	24.000
Price to Book Ratio (EOD)	Between	0-1	2.462
Net Profit Margin (MRQ)	Greater than	0	0.192
Operating Margin (MRQ)	Greater than	0	0.264
Quick Ratio (MRQ)	Greater than	1	1.819
Current Ratio (MRQ)	Greater than	1	1.990
Debt to Asset Ratio (MRQ)	Less than	1	0.377
Debt to Equity Ratio (MRQ)	Less than	1	0.606
Return on Equity (MRQ)	Greater than	0.15	0.026
Return on Assets (MRQ)	Greater than	0.05	0.016
Total			6/10 (60.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of Qiagen NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	52.853
Ma 20	Greater than	Ma 50	41.207
Ma 50	Greater than	Ma 100	42.687
Ma 100	Greater than	Ma 200	43.045
Open	Greater than	Close	41.280
Total			2/5 (40.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	6,115,190
Total Liabilities	2,307,426
Total Stockholder Equity	3,807,764

	As reported
Total Liabilities	2,307,426
Total Stockholder Equity	+ 3,807,764
Total Assets	= 6,115,190

Assets

Total Assets	6,115,190
Total Current Assets	2,147,560
Long-term Assets	3,967,630

Total Current Assets

Total Current Assets (as reported)	2,147,560
Cash And Cash Equivalents	668,084
Short-term Investments	389,698
Net Receivables	515,643
Inventory	398,385
Other Current Assets	175,750
Total Current Assets (calculated)	2,147,560
+/-	0

Long-term Assets

Long-term Assets (as reported)	3,967,630
Property Plant Equipment	870,277
Goodwill	2,475,732
Intangible Assets	526,821
Long-term Assets Other	26,717
Long-term Assets (calculated)	3,899,547
+/-	68,083

Liabilities & Shareholders' Equity

Total Current Liabilities	1,079,293
Long-term Liabilities	1,228,133
Total Stockholder Equity	3,807,764

Total Current Liabilities

Total Current Liabilities (as reported)	1,079,293
Short-term Debt	610,238
Short Long Term Debt	587,970
Accounts payable	84,155
Other Current Liabilities	318,468
Total Current Liabilities (calculated)	1,600,831
+/-	521,538

Long-term Liabilities

Long-term Liabilities (as reported)	1,228,133
Long term Debt	921,824
Capital Lease Obligations	22,268
Long-term Liabilities Other	207,401
Long-term Liabilities (calculated)	1,151,493
+/-	76,640

Total Stockholder Equity

Total Stockholder Equity (as reported)	3,807,764
Common Stock	2,702
Retained Earnings	2,456,800
Accumulated Other Comprehensive Income	-433,830
Other Stockholders Equity	1,782,092
Total Stockholder Equity (calculated)	3,807,764
+/-	0

Other

Capital Stock	2,702
Cash and Short Term Investments	1,057,782
Common Stock Shares Outstanding	223,823
Current Deferred Revenue	66,432
Liabilities and Stockholders Equity	6,115,190
Net Debt	943,041
Net Invested Capital	5,317,558
Net Working Capital	1,068,267
Property Plant and Equipment Gross	1,281,802
Short Long Term Debt Total	1,611,125

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

2003-12-31

2003-09-30

2003-06-30

2003-03-31

2002-12-31

2002-09-30

2002-06-30

2002-03-31

2001-12-31

2001-09-30

2001-06-30

2001-03-31

2000-12-31

2000-09-30

2000-06-30

2000-03-31

1999-12-31

1999-09-30

1999-06-30

1999-03-31

1998-12-31

1998-09-30

1998-06-30

1998-03-31

1997-12-31

1997-09-30

1997-06-30

1997-03-31

1996-12-31

1996-09-30

1996-06-30

1996-03-31

> Total Assets

27,400
0
0
66,200
69,900
70,400
74,500
78,900
83,900
88,700
99,500
106,700
123,400
125,600
135,332
148,117
164,453
192,967
205,822
230,261
251,238
271,888
289,661
356,968
356,968
433,257
442,518
454,511
477,015
485,407
511,584
551,930
555,878
568,359
657,598
714,599
714,599
733,039
740,030
765,298
765,298
1,149,631
1,173,272
1,212,012
1,212,012
1,261,675
2,695,787
2,775,174
2,842,246
2,873,532
2,872,876
2,885,323
2,832,373
2,970,527
3,754,651
3,796,464
3,780,199
3,767,785
3,890,524
3,913,995
3,958,055
3,998,344
3,948,442
3,756,453
3,798,106
3,876,789
3,956,454
4,125,948
4,033,574
3,976,279
4,055,086
4,088,392
4,486,512
4,563,596
4,461,240
4,454,372
4,170,198
4,131,168
4,159,431
4,189,678
4,119,562
4,118,516
4,328,144
4,308,194
4,067,741
4,556,122
5,096,544
5,038,516
5,105,356
5,309,065
5,299,027
5,748,332
5,420,364
5,382,549
5,142,744
5,235,616
5,180,952
5,294,513
5,771,477
5,971,198
5,762,610
5,907,477
6,043,429
6,146,954
6,184,282
6,153,685
6,516,617
6,287,735
6,278,953
6,347,268
5,906,698
6,115,190

6,115,190

5,906,698

6,347,268

6,278,953

6,287,735

6,516,617

6,153,685

6,184,282

6,146,954

6,043,429

5,907,477

5,762,610

5,971,198

5,771,477

5,294,513

5,180,952

5,235,616

5,142,744

5,382,549

5,420,364

5,748,332

5,299,027

5,309,065

5,105,356

5,038,516

5,096,544

4,556,122

4,067,741

4,308,194

4,328,144

4,118,516

4,119,562

4,189,678

4,159,431

4,131,168

4,170,198

4,454,372

4,461,240

4,563,596

4,486,512

4,088,392

4,055,086

3,976,279

4,033,574

4,125,948

3,956,454

3,876,789

3,798,106

3,756,453

3,948,442

3,998,344

3,958,055

3,913,995

3,890,524

3,767,785

3,780,199

3,796,464

3,754,651

2,970,527

2,832,373

2,885,323

2,872,876

2,873,532

2,842,246

2,775,174

2,695,787

1,261,675

1,212,012

1,173,272

1,149,631

765,298

740,030

733,039

714,599

657,598

568,359

555,878

551,930

511,584

485,407

477,015

454,511

442,518

433,257

356,968

289,661

271,888

251,238

230,261

205,822

192,967

164,453

148,117

135,332

125,600

123,400

106,700

99,500

88,700

83,900

78,900

74,500

70,400

69,900

66,200

27,400

> Total Current Assets

18,100
0
0
48,600
51,800
51,700
55,300
58,500
64,100
68,000
72,700
74,200
80,900
82,400
93,087
97,131
108,456
131,686
139,224
140,516
147,751
146,991
138,039
177,331
177,331
185,938
192,063
193,042
208,360
208,635
227,988
258,861
271,309
302,048
355,328
387,084
387,084
361,417
362,958
370,257
370,257
677,060
688,081
683,191
683,191
703,213
621,398
647,946
695,662
735,371
708,056
703,555
705,257
785,252
1,372,161
1,333,470
1,331,611
1,352,750
1,351,562
1,364,588
1,388,259
1,407,938
973,708
748,432
759,193
743,932
803,387
994,894
983,618
901,822
873,731
920,889
1,216,105
1,200,860
1,267,263
1,148,750
957,580
928,062
976,686
961,614
963,007
900,565
963,060
1,037,569
763,201
1,159,254
1,570,701
1,647,973
1,744,771
1,687,635
1,869,571
2,155,060
1,598,660
1,614,234
1,542,302
1,570,248
1,579,925
1,635,598
1,587,699
1,641,713
1,665,550
1,802,195
2,028,396
2,109,602
2,097,251
2,145,097
2,755,513
2,393,952
2,251,318
2,311,428
1,962,390
2,147,560

2,147,560

1,962,390

2,311,428

2,251,318

2,393,952

2,755,513

2,145,097

2,097,251

2,109,602

2,028,396

1,802,195

1,665,550

1,641,713

1,587,699

1,635,598

1,579,925

1,570,248

1,542,302

1,614,234

1,598,660

2,155,060

1,869,571

1,687,635

1,744,771

1,647,973

1,570,701

1,159,254

763,201

1,037,569

963,060

900,565

963,007

961,614

976,686

928,062

957,580

1,148,750

1,267,263

1,200,860

1,216,105

920,889

873,731

901,822

983,618

994,894

803,387

743,932

759,193

748,432

973,708

1,407,938

1,388,259

1,364,588

1,351,562

1,352,750

1,331,611

1,333,470

1,372,161

785,252

705,257

703,555

708,056

735,371

695,662

647,946

621,398

703,213

683,191

688,081

677,060

370,257

362,958

361,417

387,084

355,328

302,048

271,309

258,861

227,988

208,635

208,360

193,042

192,063

185,938

177,331

138,039

146,991

147,751

140,516

139,224

131,686

108,456

97,131

93,087

82,400

80,900

74,200

72,700

68,000

64,100

58,500

55,300

51,700

51,800

48,600

18,100

Cash And Cash Equivalents

3,700
0
0
2,000
2,200
3,600
3,100
4,300
7,400
5,600
5,500
6,300
10,300
15,300
14,342
12,140
13,872
30,618
25,364
21,534
20,262
17,759
11,297
56,460
56,460
39,497
51,786
44,893
51,228
51,639
75,261
98,993
108,774
107,327
143,068
196,375
196,375
156,995
171,192
191,700
191,700
473,457
491,984
430,357
430,357
380,371
308,685
347,320
351,561
380,667
326,034
333,313
337,036
390,311
861,273
825,557
794,770
844,209
807,752
828,407
776,581
787,865
393,850
221,133
219,855
214,008
258,229
394,037
372,757
299,819
279,988
330,303
564,272
418,934
484,210
392,667
287,811
234,330
330,951
290,011
355,785
328,157
354,646
439,180
245,446
542,841
671,751
657,714
814,923
674,413
599,842
1,159,079
552,857
624,616
700,860
623,647
656,819
688,264
465,352
597,003
787,786
759,047
617,541
880,516
770,515
706,534
1,271,597
730,669
359,180
609,549
579,935
668,084

668,084

579,935

609,549

359,180

730,669

1,271,597

706,534

770,515

880,516

617,541

759,047

787,786

597,003

465,352

688,264

656,819

623,647

700,860

624,616

552,857

1,159,079

599,842

674,413

814,923

657,714

671,751

542,841

245,446

439,180

354,646

328,157

355,785

290,011

330,951

234,330

287,811

392,667

484,210

418,934

564,272

330,303

279,988

299,819

372,757

394,037

258,229

214,008

219,855

221,133

393,850

787,865

776,581

828,407

807,752

844,209

794,770

825,557

861,273

390,311

337,036

333,313

326,034

380,667

351,561

347,320

308,685

380,371

430,357

491,984

473,457

191,700

171,192

156,995

196,375

143,068

107,327

108,774

98,993

75,261

51,639

51,228

44,893

51,786

39,497

56,460

11,297

17,759

20,262

21,534

25,364

30,618

13,872

12,140

14,342

15,300

10,300

6,300

5,500

5,600

7,400

4,300

3,100

3,600

2,200

2,000

3,700

Short-term Investments

0
0
0
28,100
26,400
25,400
26,200
25,800
25,400
25,300
25,900
23,800
23,900
21,700
28,163
32,020
36,093
32,653
37,258
37,273
37,315
35,298
23,282
22,512
22,512
18,133
11,915
11,530
11,525
11,527
11,528
6,527
6,536
42,330
62,366
30,153
30,153
51,759
40,007
15,000
15,000
10,000
0
52,782
52,782
99,300
0
2,313
0
0
0
0
0
0
0
40,000
94,000
74,000
79,552
106,077
162,346
165,624
92,497
54,577
55,503
52,319
53,084
90,451
87,784
73,379
75,763
49,923
113,701
235,834
207,814
184,036
104,479
133,217
98,578
130,817
91,474
78,282
109,693
92,999
27,943
66,006
303,195
359,198
199,269
225,774
320,888
234,606
227,534
161,344
98,325
129,586
87,865
55,981
36,602
117,249
3,946
138,974
339,777
184,785
459,285
604,429
615,387
687,597
928,161
722,352
435,843
389,698

389,698

435,843

722,352

928,161

687,597

615,387

604,429

459,285

184,785

339,777

138,974

3,946

117,249

36,602

55,981

87,865

129,586

98,325

161,344

227,534

234,606

320,888

225,774

199,269

359,198

303,195

66,006

27,943

92,999

109,693

78,282

91,474

130,817

98,578

133,217

104,479

184,036

207,814

235,834

113,701

49,923

75,763

73,379

87,784

90,451

53,084

52,319

55,503

54,577

92,497

165,624

162,346

106,077

79,552

74,000

94,000

40,000

2,313

99,300

52,782

10,000

15,000

40,007

51,759

30,153

62,366

42,330

6,536

6,527

11,528

11,527

11,525

11,530

11,915

18,133

22,512

23,282

35,298

37,315

37,273

37,258

32,653

36,093

32,020

28,163

21,700

23,900

23,800

25,900

25,300

25,400

25,800

26,200

25,400

26,400

28,100

Net Receivables

6,100
0
0
7,000
9,600
9,500
10,300
10,400
13,600
15,900
17,300
18,000
21,200
21,900
22,468
22,363
26,291
30,957
33,925
37,577
41,655
43,493
46,545
46,238
46,238
57,149
53,543
57,689
57,831
58,118
59,002
69,727
72,048
69,731
67,491
74,279
74,279
73,777
68,105
71,982
71,982
82,365
85,815
87,577
87,577
98,045
140,814
152,542
169,411
169,962
185,186
179,321
169,261
182,518
209,535
206,644
202,926
204,672
223,241
208,338
214,862
219,496
225,099
249,779
249,994
248,008
263,882
289,879
284,644
289,934
275,921
306,584
296,018
297,781
307,909
294,543
260,452
293,428
299,893
300,793
284,971
282,133
286,482
302,039
276,273
309,881
329,767
368,647
377,757
357,898
362,445
386,548
384,784
416,591
457,517
427,236
395,064
404,631
437,693
439,854
371,694
366,151
359,520
362,131
372,383
334,573
310,975
323,750
317,244
312,599
326,690
515,643

515,643

326,690

312,599

317,244

323,750

310,975

334,573

372,383

362,131

359,520

366,151

371,694

439,854

437,693

404,631

395,064

427,236

457,517

416,591

384,784

386,548

362,445

357,898

377,757

368,647

329,767

309,881

276,273

302,039

286,482

282,133

284,971

300,793

299,893

293,428

260,452

294,543

307,909

297,781

296,018

306,584

275,921

289,934

284,644

289,879

263,882

248,008

249,994

249,779

225,099

219,496

214,862

208,338

223,241

204,672

202,926

206,644

209,535

182,518

169,261

179,321

185,186

169,962

169,411

152,542

140,814

98,045

87,577

85,815

82,365

71,982

68,105

73,777

74,279

67,491

69,731

72,048

69,727

59,002

58,118

57,831

57,689

53,543

57,149

46,238

46,545

43,493

41,655

37,577

33,925

30,957

26,291

22,363

22,468

21,900

21,200

18,000

17,300

15,900

13,600

10,400

10,300

9,500

9,600

7,000

6,100

Inventory

6,700
0
0
9,900
10,600
11,400
12,400
14,600
14,900
15,900
18,000
19,900
18,000
17,200
20,688
22,498
22,273
25,147
26,390
28,899
29,877
29,817
32,333
31,883
31,883
46,142
49,903
56,113
61,121
62,947
63,650
65,160
67,168
57,757
57,484
60,164
60,164
49,311
50,298
53,653
53,653
58,184
59,315
64,085
64,085
67,237
86,947
88,346
99,095
107,768
113,733
108,563
110,089
120,110
133,618
130,851
125,118
117,808
131,245
126,633
132,752
139,365
145,531
132,236
134,358
139,589
143,173
135,293
130,645
132,646
143,157
128,097
133,412
135,779
131,525
132,276
136,090
138,438
134,074
136,586
148,593
140,090
144,710
136,552
144,033
155,667
161,948
155,927
160,195
158,235
159,968
162,912
167,093
169,520
168,266
170,704
169,340
202,804
254,642
291,181
316,280
341,041
335,691
327,525
321,621
322,831
323,472
357,960
380,824
391,989
399,207
398,385

398,385

399,207

391,989

380,824

357,960

323,472

322,831

321,621

327,525

335,691

341,041

316,280

291,181

254,642

202,804

169,340

170,704

168,266

169,520

167,093

162,912

159,968

158,235

160,195

155,927

161,948

155,667

144,033

136,552

144,710

140,090

148,593

136,586

134,074

138,438

136,090

132,276

131,525

135,779

133,412

128,097

143,157

132,646

130,645

135,293

143,173

139,589

134,358

132,236

145,531

139,365

132,752

126,633

131,245

117,808

125,118

130,851

133,618

120,110

110,089

108,563

113,733

107,768

99,095

88,346

86,947

67,237

64,085

59,315

58,184

53,653

50,298

49,311

60,164

57,484

57,757

67,168

65,160

63,650

62,947

61,121

56,113

49,903

46,142

31,883

32,333

29,817

29,877

28,899

26,390

25,147

22,273

22,498

20,688

17,200

18,000

19,900

18,000

15,900

14,900

14,600

12,400

11,400

10,600

9,900

6,700

Other Current Assets

1,600
0
0
1,600
3,000
1,800
3,300
3,400
2,800
5,300
6,000
6,200
7,500
6,300
7,426
8,110
9,927
12,311
16,287
15,233
18,642
20,624
24,582
20,238
20,238
25,017
24,916
22,817
26,655
24,404
18,547
18,454
16,783
24,903
24,919
26,113
26,113
29,575
33,356
37,922
37,922
53,054
50,967
47,317
13,403
58,260
84,952
15,138
75,595
76,974
83,103
35,566
88,871
92,313
167,735
130,418
114,797
112,061
109,772
95,133
101,718
95,588
116,731
90,707
99,483
90,008
85,019
55,363
81,806
76,669
67,855
66,290
73,063
79,671
103,971
113,771
128,381
92,990
79,054
70,339
82,184
71,903
67,529
66,799
69,506
84,859
104,040
106,487
192,627
271,315
426,428
109,161
106,436
96,352
112,190
105,464
112,603
129,014
393,410
182,299
185,844
196,982
375,867
354,645
173,447
176,730
234,082
293,976
265,909
274,939
220,715
175,750

175,750

220,715

274,939

265,909

293,976

234,082

176,730

173,447

354,645

375,867

196,982

185,844

182,299

393,410

129,014

112,603

105,464

112,190

96,352

106,436

109,161

426,428

271,315

192,627

106,487

104,040

84,859

69,506

66,799

67,529

71,903

82,184

70,339

79,054

92,990

128,381

113,771

103,971

79,671

73,063

66,290

67,855

76,669

81,806

55,363

85,019

90,008

99,483

90,707

116,731

95,588

101,718

95,133

109,772

112,061

114,797

130,418

167,735

92,313

88,871

35,566

83,103

76,974

75,595

15,138

84,952

58,260

13,403

47,317

50,967

53,054

37,922

33,356

29,575

26,113

24,919

24,903

16,783

18,454

18,547

24,404

26,655

22,817

24,916

25,017

20,238

24,582

20,624

18,642

15,233

16,287

12,311

9,927

8,110

7,426

6,300

7,500

6,200

6,000

5,300

2,800

3,400

3,300

1,800

3,000

1,600

> Long-term Assets

9,300
0
0
17,600
18,100
18,700
19,200
20,400
19,800
20,700
26,800
32,500
42,500
43,200
42,245
50,986
55,997
61,281
66,598
89,745
103,487
124,897
151,622
0
179,637
247,319
250,455
261,469
268,655
276,772
283,596
293,069
284,569
266,311
302,270
327,515
327,515
371,622
377,072
395,041
395,041
472,571
485,191
0
528,821
558,462
2,074,389
2,127,228
2,146,584
2,138,161
2,164,820
2,181,768
2,127,116
2,185,275
2,382,490
2,462,994
2,448,588
2,415,035
2,538,962
2,549,407
2,569,796
2,590,406
2,974,734
3,008,021
3,038,913
3,132,857
3,153,067
3,131,054
3,049,956
3,074,457
3,181,355
3,167,503
3,270,407
3,362,736
3,193,977
3,305,622
3,212,618
3,203,106
3,182,745
3,228,064
3,156,555
3,217,951
3,365,084
3,270,625
3,304,540
3,396,868
3,525,843
3,390,543
3,360,585
3,621,430
3,429,456
3,593,272
3,821,704
3,768,315
3,600,442
3,665,368
3,601,027
3,658,915
4,183,778
4,329,485
4,097,060
4,105,282
4,015,033
4,037,352
4,087,031
4,008,588
3,761,104
3,893,783
4,027,635
4,035,840
3,944,308
3,967,630

3,967,630

3,944,308

4,035,840

4,027,635

3,893,783

3,761,104

4,008,588

4,087,031

4,037,352

4,015,033

4,105,282

4,097,060

4,329,485

4,183,778

3,658,915

3,601,027

3,665,368

3,600,442

3,768,315

3,821,704

3,593,272

3,429,456

3,621,430

3,360,585

3,390,543

3,525,843

3,396,868

3,304,540

3,270,625

3,365,084

3,217,951

3,156,555

3,228,064

3,182,745

3,203,106

3,212,618

3,305,622

3,193,977

3,362,736

3,270,407

3,167,503

3,181,355

3,074,457

3,049,956

3,131,054

3,153,067

3,132,857

3,038,913

3,008,021

2,974,734

2,590,406

2,569,796

2,549,407

2,538,962

2,415,035

2,448,588

2,462,994

2,382,490

2,185,275

2,127,116

2,181,768

2,164,820

2,138,161

2,146,584

2,127,228

2,074,389

558,462

528,821

485,191

472,571

395,041

377,072

371,622

327,515

302,270

266,311

284,569

293,069

283,596

276,772

268,655

261,469

250,455

247,319

179,637

151,622

124,897

103,487

89,745

66,598

61,281

55,997

50,986

42,245

43,200

42,500

32,500

26,800

20,700

19,800

20,400

19,200

18,700

18,100

17,600

9,300

Property Plant Equipment

9,100
0
0
16,100
16,300
16,900
17,700
17,800
17,200
18,000
21,200
26,400
36,800
35,600
34,662
37,974
43,353
48,589
54,013
70,833
87,464
110,998
136,310
160,365
160,365
197,955
200,046
211,913
217,158
224,046
223,620
232,860
226,097
205,882
206,570
217,108
217,108
197,922
194,838
195,199
195,199
208,980
210,406
221,277
221,277
228,009
276,709
283,491
299,597
301,040
284,216
289,672
281,440
296,002
310,215
317,467
312,424
303,381
336,746
345,664
369,955
385,267
373,620
371,792
386,396
383,815
407,530
418,932
415,996
412,419
428,536
445,044
450,614
460,857
441,558
428,093
409,698
444,872
441,907
442,944
459,631
460,337
460,509
436,655
441,849
465,547
484,398
494,321
503,937
492,027
494,024
511,659
511,438
526,020
491,511
455,243
450,701
475,099
506,308
528,563
563,917
599,991
612,114
638,183
638,225
619,192
590,983
662,170
691,055
706,840
706,020
870,277

870,277

706,020

706,840

691,055

662,170

590,983

619,192

638,225

638,183

612,114

599,991

563,917

528,563

506,308

475,099

450,701

455,243

491,511

526,020

511,438

511,659

494,024

492,027

503,937

494,321

484,398

465,547

441,849

436,655

460,509

460,337

459,631

442,944

441,907

444,872

409,698

428,093

441,558

460,857

450,614

445,044

428,536

412,419

415,996

418,932

407,530

383,815

386,396

371,792

373,620

385,267

369,955

345,664

336,746

303,381

312,424

317,467

310,215

296,002

281,440

289,672

284,216

301,040

299,597

283,491

276,709

228,009

221,277

210,406

208,980

195,199

194,838

197,922

217,108

206,570

205,882

226,097

232,860

223,620

224,046

217,158

211,913

200,046

197,955

160,365

136,310

110,998

87,464

70,833

54,013

48,589

43,353

37,974

34,662

35,600

36,800

26,400

21,200

18,000

17,200

17,800

17,700

16,900

16,300

16,100

9,100

Goodwill

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,569
24,827
25,008
28,678
30,117,000
29,462
29,719
46,887
56,263
54,165
81,532
83,188
93,914
100,743
132,688
140,411
160,141
160,141
159,013
1,113,497
1,107,882
1,113,354
1,116,518
1,134,327
1,152,105
1,148,924
1,169,617
1,273,754
1,337,064
1,328,160
1,316,955
1,348,439
1,352,281
1,364,183
1,370,749
1,658,598
1,733,722
1,743,022
1,752,230
1,758,627
1,759,898
1,756,234
1,791,789
1,865,822
1,855,691
1,864,022
1,882,468
1,833,473
1,887,963
1,862,371
1,872,067
1,846,471
1,875,698
1,898,934
1,971,884
1,962,514
1,925,518
1,969,460
1,995,807
2,009,856
2,012,904
2,020,174
2,101,461
2,116,889
2,108,536
2,114,251
2,117,515
2,115,284
2,140,503
2,102,844
2,134,810
2,313,246
2,389,111
2,335,270
2,332,697
2,353,913
2,350,763
2,346,740
2,341,123
2,299,261
2,352,569
2,454,081
2,456,538
2,434,467
2,475,732

2,475,732

2,434,467

2,456,538

2,454,081

2,352,569

2,299,261

2,341,123

2,346,740

2,350,763

2,353,913

2,332,697

2,335,270

2,389,111

2,313,246

2,134,810

2,102,844

2,140,503

2,115,284

2,117,515

2,114,251

2,108,536

2,116,889

2,101,461

2,020,174

2,012,904

2,009,856

1,995,807

1,969,460

1,925,518

1,962,514

1,971,884

1,898,934

1,875,698

1,846,471

1,872,067

1,862,371

1,887,963

1,833,473

1,882,468

1,864,022

1,855,691

1,865,822

1,791,789

1,756,234

1,759,898

1,758,627

1,752,230

1,743,022

1,733,722

1,658,598

1,370,749

1,364,183

1,352,281

1,348,439

1,316,955

1,328,160

1,337,064

1,273,754

1,169,617

1,148,924

1,152,105

1,134,327

1,116,518

1,113,354

1,107,882

1,113,497

159,013

160,141

140,411

132,688

100,743

93,914

83,188

81,532

54,165

56,263

46,887

29,719

29,462

30,117,000

28,678

25,008

24,827

25,569

Long Term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,687
0
0
0
44,593
0
0
0
50,116
0
71,000
68,200
55,726
56,000
53,800
53,500
53,084
65,300
76,300
73,100
74,329
61,600
87,771
77,458
87,052
0
0
0
15,425
0
0
0
0
0
0
0
23,546
0
0
0
0

23,546

15,425

87,052

77,458

87,771

61,600

74,329

73,100

76,300

65,300

53,084

53,500

53,800

56,000

55,726

68,200

71,000

50,116

44,593

40,687

Intangible Assets

0
0
0
900
900
900
900
1,800
1,800
1,800
4,200
4,600
4,200
3,900
4,087
8,722
8,466
8,050
7,790
7,117
6,544
6,172
5,915
7,140
7,140
38,855
39,367
38,319
37,330
37,765
42,870
44,638
43,420
43,177
74,830
91,021
91,021
143,771
148,555
168,480
168,480
107,948
106,539
118,492
118,492
132,821
648,860
639,107
631,078
618,908
633,173
640,309
620,005
619,380
693,777
752,296
745,800
713,664
777,428
753,327
752,541
741,390
854,199
819,487
824,059
906,763
886,899
853,872
810,359
798,226
809,759
790,405
761,411
768,054
704,710
726,914
670,881
661,437
635,357
636,421
614,113
593,674
623,272
557,159
559,161
546,841
524,672
499,318
499,919
565,378
504,861
475,043
709,361
680,697
645,076
632,434
603,690
600,713
769,902
883,600
695,937
667,273
638,786
627,436
607,738
594,439
551,587
544,796
585,021
570,192
542,604
526,821

526,821

542,604

570,192

585,021

544,796

551,587

594,439

607,738

627,436

638,786

667,273

695,937

883,600

769,902

600,713

603,690

632,434

645,076

680,697

709,361

475,043

504,861

565,378

499,919

499,318

524,672

546,841

559,161

557,159

623,272

593,674

614,113

636,421

635,357

661,437

670,881

726,914

704,710

768,054

761,411

790,405

809,759

798,226

810,359

853,872

886,899

906,763

824,059

819,487

854,199

741,390

752,541

753,327

777,428

713,664

745,800

752,296

693,777

619,380

620,005

640,309

633,173

618,908

631,078

639,107

648,860

132,821

118,492

106,539

107,948

168,480

148,555

143,771

91,021

74,830

43,177

43,420

44,638

42,870

37,765

37,330

38,319

39,367

38,855

7,140

5,915

6,172

6,544

7,117

7,790

8,050

8,466

8,722

4,087

3,900

4,200

4,600

4,200

1,800

900

Long-term Assets Other

200
0
0
600
900
900
600
800
800
900
1,400
1,500
1,500
3,700
3,496
4,290
4,178
4,642
4,795
11,795
9,479
7,727
9,397
10,328
10,328
8,705
9,238
8,211
11,712
12,360
11,810
10,967
10,627
14,709
18,254
16,272
16,272
21,803
26,050
25,016
25,016
18,520
23,572
26,502
26,502
27,541
27,789
24,620
27,463
31,859
35,278
25,916
26,650
23,948
26,728
29,780
34,062
51,833
46,717
60,953
52,072
67,145
67,407
56,154
59,596
49,406
53,246
59,985
63,166
67,488
70,823
71,282
189,282
245,829
208,211
258,354
261,785
216,588
251,978
270,965
179,150
186,110
311,118
306,357
270,527
322,595
436,774
349,424
294,371
437,978
281,592
464,536
197,595
415,978
120,924
188,380
178,741
166,094
174,657
423,770
158,527
161,553
157,118
157,644
421,998
383,592
130,064
254,395
297,478
302,270
261,217
26,717

26,717

261,217

302,270

297,478

254,395

130,064

383,592

421,998

157,644

157,118

161,553

158,527

423,770

174,657

166,094

178,741

188,380

120,924

415,978

197,595

464,536

281,592

437,978

294,371

349,424

436,774

322,595

270,527

306,357

311,118

186,110

179,150

270,965

251,978

216,588

261,785

258,354

208,211

245,829

189,282

71,282

70,823

67,488

63,166

59,985

53,246

49,406

59,596

56,154

67,407

67,145

52,072

60,953

46,717

51,833

34,062

29,780

26,728

23,948

26,650

25,916

35,278

31,859

27,463

24,620

27,789

27,541

26,502

23,572

18,520

25,016

26,050

21,803

16,272

18,254

14,709

10,627

10,967

11,810

12,360

11,712

8,211

9,238

8,705

10,328

9,397

7,727

9,479

11,795

4,795

4,642

4,178

4,290

3,496

3,700

1,500

1,400

900

800

600

900

600

200

> Total Liabilities

14,300
0
0
18,500
22,300
21,800
23,500
24,900
26,800
27,300
33,300
33,600
46,800
45,300
44,859
55,455
46,144
65,833
59,225
65,683
78,220
87,281
91,474
143,993
143,993
172,689
175,717
191,480
201,108
193,402
198,917
217,144
210,730
218,057
290,071
314,223
314,223
320,087
302,421
314,841
314,841
641,011
644,533
645,847
645,847
644,431
1,367,321
1,383,046
1,390,587
1,393,834
1,414,740
1,431,479
1,369,934
1,435,913
1,526,342
1,505,295
1,469,134
1,433,242
1,460,055
1,437,642
1,421,760
1,404,117
1,363,919
1,198,655
1,163,061
1,235,134
1,244,668
1,401,585
1,342,785
1,380,981
1,378,842
1,364,521
1,753,924
1,808,819
1,747,575
1,796,373
1,691,455
1,593,731
1,639,152
1,627,724
1,494,964
1,492,002
1,662,444
1,701,098
1,637,937
2,050,748
2,529,948
2,497,520
2,524,816
2,785,205
2,771,724
3,113,362
2,814,308
2,750,158
2,675,302
2,699,025
2,689,337
2,673,662
3,060,344
3,488,149
2,912,834
2,929,605
3,029,689
3,050,404
2,944,144
2,871,274
3,188,857
2,821,124
2,717,777
2,723,660
2,212,998
2,307,426

2,307,426

2,212,998

2,723,660

2,717,777

2,821,124

3,188,857

2,871,274

2,944,144

3,050,404

3,029,689

2,929,605

2,912,834

3,488,149

3,060,344

2,673,662

2,689,337

2,699,025

2,675,302

2,750,158

2,814,308

3,113,362

2,771,724

2,785,205

2,524,816

2,497,520

2,529,948

2,050,748

1,637,937

1,701,098

1,662,444

1,492,002

1,494,964

1,627,724

1,639,152

1,593,731

1,691,455

1,796,373

1,747,575

1,808,819

1,753,924

1,364,521

1,378,842

1,380,981

1,342,785

1,401,585

1,244,668

1,235,134

1,163,061

1,198,655

1,363,919

1,404,117

1,421,760

1,437,642

1,460,055

1,433,242

1,469,134

1,505,295

1,526,342

1,435,913

1,369,934

1,431,479

1,414,740

1,393,834

1,390,587

1,383,046

1,367,321

644,431

645,847

644,533

641,011

314,841

302,421

320,087

314,223

290,071

218,057

210,730

217,144

198,917

193,402

201,108

191,480

175,717

172,689

143,993

91,474

87,281

78,220

65,683

59,225

65,833

46,144

55,455

44,859

45,300

46,800

33,600

33,300

27,300

26,800

24,900

23,500

21,800

22,300

18,500

14,300

> Total Current Liabilities

8,100
0
0
12,700
16,900
16,600
18,300
19,800
22,000
22,400
27,700
28,000
31,400
26,700
28,311
39,918
29,712
43,042
37,888
42,576
51,850
51,456
52,301
57,883
57,883
69,946
68,474
81,488
85,809
74,932
82,287
95,278
91,298
99,953
68,247
88,055
88,055
89,439
76,779
91,671
91,671
107,675
111,988
116,531
116,531
126,836
187,467
165,731
169,735
182,917
214,905
262,375
222,519
264,453
376,070
375,530
338,140
322,011
395,155
388,407
374,889
365,300
648,180
481,657
451,998
512,117
539,277
300,382
268,884
296,926
303,490
337,038
313,599
295,750
435,619
431,626
332,723
264,663
277,332
268,353
246,232
248,441
250,121
308,429
273,532
300,781
294,704
324,792
815,354
941,194
1,368,590
972,189
943,841
909,754
630,704
951,345
997,195
956,683
1,090,625
613,806
499,384
503,117
1,070,031
1,517,470
957,283
962,904
1,497,538
974,523
890,244
978,450
524,371
1,079,293

1,079,293

524,371

978,450

890,244

974,523

1,497,538

962,904

957,283

1,517,470

1,070,031

503,117

499,384

613,806

1,090,625

956,683

997,195

951,345

630,704

909,754

943,841

972,189

1,368,590

941,194

815,354

324,792

294,704

300,781

273,532

308,429

250,121

248,441

246,232

268,353

277,332

264,663

332,723

431,626

435,619

295,750

313,599

337,038

303,490

296,926

268,884

300,382

539,277

512,117

451,998

481,657

648,180

365,300

374,889

388,407

395,155

322,011

338,140

375,530

376,070

264,453

222,519

262,375

214,905

182,917

169,735

165,731

187,467

126,836

116,531

111,988

107,675

91,671

76,779

89,439

88,055

68,247

99,953

91,298

95,278

82,287

74,932

85,809

81,488

68,474

69,946

57,883

52,301

51,456

51,850

42,576

37,888

43,042

29,712

39,918

28,311

26,700

31,400

28,000

27,700

22,400

22,000

19,800

18,300

16,600

16,900

12,700

8,100

Short-term Debt

2,300
0
0
3,200
5,100
5,800
4,700
5,300
6,500
4,600
7,400
9,100
10,600
6,500
6,677
18,153
5,916
9,458
7,900
8,324
12,258
6,494
7,580
8,542
8,542
10,251
6,634
3,274
10,827
2,589
2,616
9,229
8,818
2,641
1,104
7,970
7,970
7,187
7,031
6,916
6,916
7,222
7,166
7,422
7,422
14,356
2,684
2,773
2,962
2,956
28,011
27,984
27,976
28,063
53,342
53,417
53,380
54,323
78,982
75,835
76,332
76,807
351,661
143,946
149,003
215,682
221,103
948
912
727
326
207
414
410
130,828
131,119
647
615
490
922
-45,718
-50,984
-7,671
999
-40,495
1,396,330
-70,143
1,359
417,907
420,993
701,366
503,116
351,201
353,616
134,081
285,244
325,291
305,776
369,736
65,989
-54,423
-22,824
371,637
847,626
468,792
460,267
866,040
389,552
393,243
500,149
100,608
610,238

610,238

100,608

500,149

393,243

389,552

866,040

460,267

468,792

847,626

371,637

-22,824

-54,423

65,989

369,736

305,776

325,291

285,244

134,081

353,616

351,201

503,116

701,366

420,993

417,907

1,359

-70,143

1,396,330

-40,495

999

-7,671

-50,984

-45,718

922

490

615

647

131,119

130,828

410

414

207

326

727

912

948

221,103

215,682

149,003

143,946

351,661

76,807

76,332

75,835

78,982

54,323

53,380

53,417

53,342

28,063

27,976

27,984

28,011

2,956

2,962

2,773

2,684

14,356

7,422

7,166

7,222

6,916

7,031

7,187

7,970

1,104

2,641

8,818

9,229

2,616

2,589

10,827

3,274

6,634

10,251

8,542

7,580

6,494

12,258

8,324

7,900

9,458

5,916

18,153

6,677

6,500

10,600

9,100

7,400

4,600

6,500

5,300

4,700

5,800

5,100

3,200

2,300

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
850,202
0
0
0
131,119
0
0
0
1,049,948
0
1,072,000
1,075,840
1,068,095
1,073,763
1,396,330
1,769,994
200
417,907
420,993
701,366
503,616
351,201
353,616
72,983
285,244
325,291
305,776
369,736
42,539
0
0
371,637
847,626
468,792
460,267
866,040
389,552
393,243
500,149
100,608
587,970

587,970

100,608

500,149

393,243

389,552

866,040

460,267

468,792

847,626

371,637

42,539

369,736

305,776

325,291

285,244

72,983

353,616

351,201

503,616

701,366

420,993

417,907

200

1,769,994

1,396,330

1,073,763

1,068,095

1,075,840

1,072,000

1,049,948

131,119

850,202

Accounts payable

2,600
0
0
5,600
4,700
4,500
4,800
6,700
5,200
6,900
7,500
9,200
7,900
8,000
8,136
10,468
11,467
13,208
13,300
16,658
17,107
20,257
16,615
20,262
20,262
20,453
18,377
23,661
20,670
18,653
17,047
19,481
14,449
16,668
13,369
20,157
20,157
17,417
14,312
15,934
15,934
22,019
33,295
23,806
23,806
20,315
35,409
40,379
37,822
39,354
41,158
48,836
38,978
38,645
42,078
43,775
45,572
49,007
65,067
47,803
51,976
49,573
44,900
59,848
42,099
60,694
56,091
51,311
40,760
43,467
40,098
50,869
40,930
44,183
42,055
46,124
45,074
42,207
41,938
52,306
38,930
45,563
40,874
51,218
44,575
48,500
50,550
59,205
46,501
60,942
59,912
69,415
63,237
56,526
64,816
84,767
71,139
94,850
90,859
118,153
103,471
103,004
94,265
101,224
87,012
85,195
82,836
98,734
84,386
83,939
76,887
84,155

84,155

76,887

83,939

84,386

98,734

82,836

85,195

87,012

101,224

94,265

103,004

103,471

118,153

90,859

94,850

71,139

84,767

64,816

56,526

63,237

69,415

59,912

60,942

46,501

59,205

50,550

48,500

44,575

51,218

40,874

45,563

38,930

52,306

41,938

42,207

45,074

46,124

42,055

44,183

40,930

50,869

40,098

43,467

40,760

51,311

56,091

60,694

42,099

59,848

44,900

49,573

51,976

47,803

65,067

49,007

45,572

43,775

42,078

38,645

38,978

48,836

41,158

39,354

37,822

40,379

35,409

20,315

23,806

33,295

22,019

15,934

14,312

17,417

20,157

13,369

16,668

14,449

19,481

17,047

18,653

20,670

23,661

18,377

20,453

20,262

16,615

20,257

17,107

16,658

13,300

13,208

11,467

10,468

8,136

8,000

7,900

9,200

7,500

6,900

5,200

6,700

4,800

4,500

4,700

5,600

2,600

Other Current Liabilities

3,200
0
0
3,900
7,100
6,300
8,800
7,800
10,300
10,900
12,800
9,700
12,900
12,200
13,498
11,297
12,329
20,376
16,688
1,706
2,588
2,750
4,074
20,645
8,434
9,907
12,309
-5,980,447
40,860
43,129
54,393
-8,027,432
61,884
73,485
41,677
-2,706,072
-2,706,072
63,103
43,518
-1,110,179
-1,110,179
76,081
69,556
85,303
-5,274,697
86,099
145,633
113,645
122,212
133,979
137,874
173,506
148,966
189,049
270,394
259,426
221,691
202,325
233,432
234,265
215,772
207,701
215,778
244,980
226,954
200,092
-29,035,917
220,827
224,222
-29,122,268
-30,783,934
235,320
-35,366,745
-32,609,843
-31,571,264
205,193
-31,392,998
218,842
234,904
165,313
207,302
202,878
209,247
211,583
228,957
252,281
244,154
214,871
308,762
455,934
605,956
354,300
496,553
506,931
395,366
532,809
539,350
534,185
586,781
372,598
395,913
400,113
521,079
505,252
401,479
347,200
548,662
417,237
341,615
325,962
283,476
318,468

318,468

283,476

325,962

341,615

417,237

548,662

347,200

401,479

505,252

521,079

400,113

395,913

372,598

586,781

534,185

539,350

532,809

395,366

506,931

496,553

354,300

605,956

455,934

308,762

214,871

244,154

252,281

228,957

211,583

209,247

202,878

207,302

165,313

234,904

218,842

-31,392,998

205,193

-31,571,264

-32,609,843

-35,366,745

235,320

-30,783,934

-29,122,268

224,222

220,827

-29,035,917

200,092

226,954

244,980

215,778

207,701

215,772

234,265

233,432

202,325

221,691

259,426

270,394

189,049

148,966

173,506

137,874

133,979

122,212

113,645

145,633

86,099

-5,274,697

85,303

69,556

76,081

-1,110,179

43,518

63,103

-2,706,072

41,677

73,485

61,884

-8,027,432

54,393

43,129

40,860

-5,980,447

12,309

9,907

8,434

20,645

4,074

2,750

2,588

1,706

16,688

20,376

12,329

11,297

13,498

12,200

12,900

9,700

12,800

10,900

10,300

7,800

8,800

6,300

7,100

3,900

3,200

> Long-term Liabilities

6,200
0
0
5,800
5,400
5,200
5,200
5,100
4,800
4,900
5,600
5,600
15,400
18,600
16,548
15,537
16,432
22,791
21,337
23,107
26,370
35,825
39,173
0
86,110
102,743
107,243
109,992
115,299
118,470
116,630
121,866
119,432
118,104
221,824
226,168
226,168
230,648
225,642
223,170
223,170
533,336
532,545
0
529,316
517,595
1,179,854
1,217,315
1,220,852
1,210,917
1,199,835
1,169,104
1,147,415
1,171,460
1,150,272
1,129,765
1,130,994
1,111,231
1,064,900
1,049,235
1,046,871
1,038,817
715,739
716,998
711,063
723,017
705,391
1,101,203
1,073,901
1,084,055
1,075,352
1,027,483
1,440,325
1,513,069
1,311,956
1,364,747
1,358,732
1,329,068
1,361,820
1,359,371
1,248,732
1,243,561
1,412,323
1,392,669
1,364,405
1,749,967
2,235,244
2,172,728
1,709,462
1,844,011
1,403,134
2,141,173
1,870,467
1,840,404
2,044,598
1,747,680
1,692,142
1,716,979
1,969,719
2,874,343
2,413,450
2,426,488
1,959,658
1,532,934
1,986,861
1,908,370
1,691,319
1,846,601
1,827,533
1,745,210
1,688,627
1,228,133

1,228,133

1,688,627

1,745,210

1,827,533

1,846,601

1,691,319

1,908,370

1,986,861

1,532,934

1,959,658

2,426,488

2,413,450

2,874,343

1,969,719

1,716,979

1,692,142

1,747,680

2,044,598

1,840,404

1,870,467

2,141,173

1,403,134

1,844,011

1,709,462

2,172,728

2,235,244

1,749,967

1,364,405

1,392,669

1,412,323

1,243,561

1,248,732

1,359,371

1,361,820

1,329,068

1,358,732

1,364,747

1,311,956

1,513,069

1,440,325

1,027,483

1,075,352

1,084,055

1,073,901

1,101,203

705,391

723,017

711,063

716,998

715,739

1,038,817

1,046,871

1,049,235

1,064,900

1,111,231

1,130,994

1,129,765

1,150,272

1,171,460

1,147,415

1,169,104

1,199,835

1,210,917

1,220,852

1,217,315

1,179,854

517,595

529,316

532,545

533,336

223,170

225,642

230,648

226,168

221,824

118,104

119,432

121,866

116,630

118,470

115,299

109,992

107,243

102,743

86,110

39,173

35,825

26,370

23,107

21,337

22,791

16,432

15,537

16,548

18,600

15,400

5,600

4,900

4,800

5,100

5,200

5,400

5,800

6,200

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,354,072
1,341,496
1,066,853
1,671,090
1,397,553
1,410,557
1,688,762
1,421,108
1,387,316
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1,387,316

1,421,108

1,688,762

1,410,557

1,397,553

1,671,090

1,066,853

1,341,496

1,354,072

Other Liabilities

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
329
513
521
541
4,004
9,529
8,565
4,927
4,950
3,318
3,738
3,152
5,064
4,771
3,052
7,706
7,871
6,896
8,536
4,676
7,653
8,668
3,954
3,052
3,538
5,370
4,530
6,010
5,770
6,006
12,974
8,405
10,832
10,567
7,132
5,406
10,401
11,615
13,945
47,075
25,061
13,218
36,209
51,397
32,246
34,884
26,413
63,881
35,362
35,849
38,926
58,746
28,772
31,269
23,027
38,447
120,070
194,476
146,965
206,523
202,142
168,153
199,096
224,058
143,227
120,165
302,526
284,952
250,147
324,524
446,658
337,743
312,590
472,815
311,181
451,793
422,756
375,478
313,671
280,914
304,826
577,916
547,441
516,401
475,612
475,848
386,678
438,790
510,042
433,115
262,279
411,928
0
303,111
256,445
0

256,445

303,111

411,928

262,279

433,115

510,042

438,790

386,678

475,848

475,612

516,401

547,441

577,916

304,826

280,914

313,671

375,478

422,756

451,793

311,181

472,815

312,590

337,743

446,658

324,524

250,147

284,952

302,526

120,165

143,227

224,058

199,096

168,153

202,142

206,523

146,965

194,476

120,070

38,447

23,027

31,269

28,772

58,746

38,926

35,849

35,362

63,881

26,413

34,884

32,246

51,397

36,209

13,218

25,061

47,075

13,945

11,615

10,401

5,406

7,132

10,567

10,832

8,405

12,974

6,006

5,770

6,010

4,530

5,370

3,538

3,052

3,954

8,668

7,653

4,676

8,536

6,896

7,871

7,706

3,052

4,771

5,064

3,152

3,738

3,318

4,950

4,927

8,565

9,529

4,004

541

521

513

329

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
117,264
0
0
0
69,610
0
0
0
40,621
0
0
0
76,727
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,930
0
0
0
33,123
0
0
0
0

33,123

28,930

76,727

40,621

69,610

117,264

> Total Stockholder Equity

13,100
0
0
47,700
47,600
48,600
51,000
54,000
57,100
61,400
66,100
73,000
76,400
80,000
90,192
92,393
118,046
126,887
146,415
164,385
173,018
184,607
198,187
212,975
212,975
260,568
266,801
263,031
275,907
292,005
312,667
334,786
345,148
350,302
367,527
400,376
400,376
412,952
437,609
450,457
450,457
508,620
528,739
566,165
566,165
617,244
1,327,969
1,391,575
1,451,046
1,479,029
1,457,760
1,453,844
1,462,439
1,534,614
2,228,309
2,291,169
2,311,065
2,334,543
2,430,469
2,476,353
2,536,295
2,594,227
2,542,755
2,548,304
2,625,354
2,632,149
2,702,123
2,714,704
2,681,015
2,585,770
2,666,368
2,714,332
2,723,684
2,745,767
2,705,306
2,649,744
2,471,184
2,533,708
2,517,981
2,559,920
2,624,598
2,621,082
2,665,700
2,607,096
2,429,804
2,505,374
2,566,596
2,540,996
2,580,540
2,523,860
2,527,303
2,634,970
2,606,056
2,632,391
2,467,442
2,536,591
2,491,615
2,620,851
2,711,133
2,483,049
2,849,776
2,977,872
3,013,740
3,096,550
3,240,138
3,282,411
3,327,760
3,466,611
3,561,176
3,623,608
3,693,700
3,807,764

3,807,764

3,693,700

3,623,608

3,561,176

3,466,611

3,327,760

3,282,411

3,240,138

3,096,550

3,013,740

2,977,872

2,849,776

2,483,049

2,711,133

2,620,851

2,491,615

2,536,591

2,467,442

2,632,391

2,606,056

2,634,970

2,527,303

2,523,860

2,580,540

2,540,996

2,566,596

2,505,374

2,429,804

2,607,096

2,665,700

2,621,082

2,624,598

2,559,920

2,517,981

2,533,708

2,471,184

2,649,744

2,705,306

2,745,767

2,723,684

2,714,332

2,666,368

2,585,770

2,681,015

2,714,704

2,702,123

2,632,149

2,625,354

2,548,304

2,542,755

2,594,227

2,536,295

2,476,353

2,430,469

2,334,543

2,311,065

2,291,169

2,228,309

1,534,614

1,462,439

1,453,844

1,457,760

1,479,029

1,451,046

1,391,575

1,327,969

617,244

566,165

528,739

508,620

450,457

437,609

412,952

400,376

367,527

350,302

345,148

334,786

312,667

292,005

275,907

263,031

266,801

260,568

212,975

198,187

184,607

173,018

164,385

146,415

126,887

118,046

92,393

90,192

80,000

76,400

73,000

66,100

61,400

57,100

54,000

51,000

48,600

47,600

47,700

13,100

Common Stock

200
0
0
300
300
300
300
300
300
300
300
300
300
600
350
351
353
1,347
1,351
1,443
1,451
1,454
1,455
1,458
1,458
1,476
1,477
1,478
1,479
1,479
1,484
1,485
1,489
1,490
1,493
1,495
1,495
1,505
1,509
1,513
1,513
1,526
1,529
1,535
1,535
1,542
2,138
2,175
2,190
2,193
2,205
2,212
2,218
2,228
2,697
2,711
2,715
2,720
2,721
2,724
2,732
2,735
2,738
2,739
2,751
2,761
2,768
2,769
2,801
2,808
2,812
2,812
2,812
2,812
2,812
2,812
2,812
2,812
2,812
2,812
2,812
2,812
2,812
2,812
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702
2,702

2,702

2,812

2,808

2,801

2,769

2,768

2,761

2,751

2,739

2,738

2,735

2,732

2,724

2,721

2,720

2,715

2,711

2,697

2,228

2,218

2,212

2,205

2,193

2,190

2,175

2,138

1,542

1,535

1,529

1,526

1,513

1,509

1,505

1,495

1,493

1,490

1,489

1,485

1,484

1,479

1,478

1,477

1,476

1,458

1,455

1,454

1,451

1,443

1,351

1,347

353

351

350

600

300

200

Retained Earnings

3,400
0
0
7,800
9,700
11,700
13,700
16,600
19,400
19,000
22,200
25,800
29,600
33,600
38,100
38,458
43,681
47,246
53,727
60,311
68,808
80,151
86,344
97,278
97,278
111,358
118,647
120,420
131,415
142,518
154,283
163,270
174,691
183,493
196,133
211,975
211,975
239,700
257,340
274,200
274,200
305,934
325,292
344,739
344,739
381,107
373,779
388,779
409,112
432,338
453,129
477,812
502,496
533,425
571,115
615,579
648,593
687,112
723,601
759,890
787,871
821,159
856,304
855,928
884,520
917,852
947,015
1,029,425
1,005,417
953,656
994,357
1,050,239
1,063,190
1,079,250
1,101,396
990,951
1,136,971
1,148,549
1,181,136
968,353
1,235,667
1,243,888
1,273,605
929,625
1,240,484
1,241,764
1,289,603
1,027,186
1,243,503
1,268,140
1,321,094
1,068,980
1,342,409
1,371,445
1,210,359
868,838
1,187,644
1,262,077
1,271,964
758,533
1,430,528
1,537,485
1,665,666
1,465,070
1,913,660
1,990,596
2,072,575
2,160,173
1,819,166
1,865,160
1,922,193
2,456,800

2,456,800

1,922,193

1,865,160

1,819,166

2,160,173

2,072,575

1,990,596

1,913,660

1,465,070

1,665,666

1,537,485

1,430,528

758,533

1,271,964

1,262,077

1,187,644

868,838

1,210,359

1,371,445

1,342,409

1,068,980

1,321,094

1,268,140

1,243,503

1,027,186

1,289,603

1,241,764

1,240,484

929,625

1,273,605

1,243,888

1,235,667

968,353

1,181,136

1,148,549

1,136,971

990,951

1,101,396

1,079,250

1,063,190

1,050,239

994,357

953,656

1,005,417

1,029,425

947,015

917,852

884,520

855,928

856,304

821,159

787,871

759,890

723,601

687,112

648,593

615,579

571,115

533,425

502,496

477,812

453,129

432,338

409,112

388,779

373,779

381,107

344,739

325,292

305,934

274,200

257,340

239,700

211,975

196,133

183,493

174,691

163,270

154,283

142,518

131,415

120,420

118,647

111,358

97,278

86,344

80,151

68,808

60,311

53,727

47,246

43,681

38,458

38,100

33,600

29,600

25,800

22,200

19,000

19,400

16,600

13,700

11,700

9,700

7,800

3,400

Accumulated Other Comprehensive Income

200
0
0
-1,000
-3,100
-4,400
-4,200
-4,500
-4,900
-4,600
-3,500
-2,400
-4,000
-5,000
-3,557
-4,568
-5,787
-6,109
-7,796
-430
-7,224
-10,931
-7,162
-42,726
-8,878
128
-1,421
6,586
8,302
12,953
17,508
29,992
26,537
21,550
24,542
40,675
40,675
19,140
22,648
16,948
16,948
33,951
31,299
-131,650
41,235
48,399
65,854
75,024
102,501
101,797
46,657
15,155
-5,979
24,469
48,279
50,146
30,271
7,055
61,674
64,754
86,619
103,404
9,155
15,904
46,563
9,077
38,861
43,991
20,510
-29,935
1,307
-4,192
7,628
13,067
-75,079
-134,735
-235,314
-195,842
-245,518
-259,156
-215,995
-248,871
-249,070
-333,839
-295,196
-244,791
-225,580
-220,759
-205,564
-279,644
-305,173
-310,644
-318,604
-314,090
-353,116
-309,619
-387,529
-351,611
-292,934
-239,600
-266,245
-260,966
-291,601
-326,670
-333,822
-391,421
-440,933
-404,091
-396,261
-417,902
-438,687
-433,830

-433,830

-438,687

-417,902

-396,261

-404,091

-440,933

-391,421

-333,822

-326,670

-291,601

-260,966

-266,245

-239,600

-292,934

-351,611

-387,529

-309,619

-353,116

-314,090

-318,604

-310,644

-305,173

-279,644

-205,564

-220,759

-225,580

-244,791

-295,196

-333,839

-249,070

-248,871

-215,995

-259,156

-245,518

-195,842

-235,314

-134,735

-75,079

13,067

7,628

-4,192

1,307

-29,935

20,510

43,991

38,861

9,077

46,563

15,904

9,155

103,404

86,619

64,754

61,674

7,055

30,271

50,146

48,279

24,469

-5,979

15,155

46,657

101,797

102,501

75,024

65,854

48,399

41,235

-131,650

31,299

33,951

16,948

22,648

19,140

40,675

24,542

21,550

26,537

29,992

17,508

12,953

8,302

6,586

-1,421

128

-8,878

-42,726

-7,162

-10,931

-7,224

-430

-7,796

-6,109

-5,787

-4,568

-3,557

-5,000

-4,000

-2,400

-3,500

-4,600

-4,900

-4,500

-4,200

-4,400

-3,100

-1,000

200

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,640,201
1,649,368
1,660,705
1,742,191
1,722,185
1,734,421
1,769,122
1,777,017
1,785,696
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1,785,696

1,777,017

1,769,122

1,734,421

1,722,185

1,742,191

1,660,705

1,649,368

1,640,201

Treasury Stock

-96,898

-111,966

-161,625

-162,087

-142,636

-178,903

-152,025

-116,706

-100,302

-118,987

-123,474

-63,705

-77,489

-120,006

-126,300

-131,868

-145,029

-152,412

-155,810

-154,213

-155,216

-167,190

-135,779

-150,853

-142,691

-116,613

-102,717

-98,993

-96,435

-35,653

Other Stockholders Equity

9,300
0
0
40,600
40,700
41,000
41,200
41,600
42,300
46,700
47,100
49,300
50,500
50,800
55,299
75,092
95,520
99,802
112,845
133,477
133,605
133,848
110,388
0
156,965
190,460
189,403
208,389
210,269
215,264
224,156
262,545
261,482
257,833
262,415
287,262
287,262
272,103
279,116
279,932
279,932
306,348
307,106
0
351,541
366,245
1,083,702
1,167,100
1,206,223
1,210,977
1,168,905
1,167,890
957,725
998,961
1,654,497
1,622,879
1,659,757
1,644,711
1,704,147
1,648,739
1,745,692
1,770,333
1,674,713
1,673,637
1,691,083
1,702,536
1,713,340
1,682,501
1,651,797
1,659,306
1,668,199
1,661,089
1,649,682
1,650,705
1,676,098
1,656,246
1,566,401
1,578,347
1,580,033
1,588,599
1,602,119
1,623,382
1,638,283
1,674,820
1,481,618
1,505,908
1,500,291
1,511,349
1,540,335
1,533,018
1,508,507
1,563,644
1,579,945
1,572,244
1,607,381
1,665,432
1,689,269
1,708,072
1,729,467
1,472,046
2,039,010
2,082,735
1,636,973
1,628,778
1,657,598
1,680,534
1,693,416
1,707,827
1,739,308
1,755,746
1,768,805
1,782,092

1,782,092

1,768,805

1,755,746

1,739,308

1,707,827

1,693,416

1,680,534

1,657,598

1,628,778

1,636,973

2,082,735

2,039,010

1,472,046

1,729,467

1,708,072

1,689,269

1,665,432

1,607,381

1,572,244

1,579,945

1,563,644

1,508,507

1,533,018

1,540,335

1,511,349

1,500,291

1,505,908

1,481,618

1,674,820

1,638,283

1,623,382

1,602,119

1,588,599

1,580,033

1,578,347

1,566,401

1,656,246

1,676,098

1,650,705

1,649,682

1,661,089

1,668,199

1,659,306

1,651,797

1,682,501

1,713,340

1,702,536

1,691,083

1,673,637

1,674,713

1,770,333

1,745,692

1,648,739

1,704,147

1,644,711

1,659,757

1,622,879

1,654,497

998,961

957,725

1,167,890

1,168,905

1,210,977

1,206,223

1,167,100

1,083,702

366,245

351,541

307,106

306,348

279,932

279,116

272,103

287,262

262,415

257,833

261,482

262,545

224,156

215,264

210,269

208,389

189,403

190,460

156,965

110,388

133,848

133,605

133,477

112,845

99,802

95,520

75,092

55,299

50,800

50,500

49,300

47,100

46,700

42,300

41,600

41,200

41,000

40,700

40,600

9,300

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31
Accounts Payable	84,155	98,734	101,224	118,153	84,767	69,415	59,205	51,218	52,306	46,124	50,869	51,311	59,848	47,803	43,775	48,836	40,379	23,806	15,934	20,157	19,481	23,661	20,262	16,658	10,468	9,200	6,700	5,600	2,900
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-433,830	-404,091	-326,670	-239,600	-309,619	-310,644	-220,759	-333,839	-259,156	-134,735	-4,192	43,991	15,904	64,754	50,146	15,155	75,024	41,235	16,948	40,675	29,992	6,586	-8,878	-430	-4,568	-2,400	-4,500	-1,000	2,000
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	22,268	22,220	22,048	23,450	18,739	61	1,359	999	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	2,702	2,702	2,702	2,702	2,702	2,702	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	0	0	0	1,777,017	1,742,191	1,630,095	1,794,665	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	668,084	730,669	880,516	597,003	623,647	1,159,079	657,714	439,180	290,011	392,667	330,303	394,037	221,133	828,407	825,557	333,313	347,320	430,357	191,700	196,375	98,993	44,893	56,460	21,534	12,140	6,300	4,300	2,000	5,300
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	1,057,782	1,418,266	1,065,301	714,252	753,233	1,393,685	1,016,912	532,179	420,828	576,703	380,226	484,488	275,710	934,484	865,557	333,313	349,633	483,139	206,700	226,528	105,520	56,423	78,972	58,807	44,160	30,100	30,100	30,100	5,300
Common Stock	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,812	2,812	2,812	2,812	2,769	2,739	2,724	2,711	2,212	2,175	1,535	1,513	1,495	1,485	1,478	1,458	1,443	351	300	300	300	200
Common Stock Shares Outstanding	223,700	223,232	225,073	227,188	232,420	233,456	233,009	230,141	228,374	232,592	233,206	231,829	230,210	231,576	205,700	196,694	169,442	147,831	144,610	143,018	141,722	140,387	139,683	139,698	133,746	140,871	121,058	102,074	77,037
Common Stock Total Equity	0	0	0	2,702	2,702	2,702	2,702	2,812	2,812	2,812	2,812	2,769	2,739	2,724	2,711	2,212	2,175	1,535	1,513	1,495	1,485	1,478	1,458	1,443	351	300	0	0	0
Current Deferred Revenue	66,432	69,000	63,368	57,066	48,525	45,358	49,357	44,629	49,812	49,190	50,642	27,296	32,883	30,504	18,912	12,049	8,934	5,360,000	1,179,000	2,766,000	8,094,000	6,035,000	20,645	15,888	0	0	0	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	33,123	28,930	25,386	0	0	76,727	40,621	69,610	117,264	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	2,475,732	2,352,569	2,350,763	2,389,111	2,140,503	2,108,536	2,012,904	1,925,518	1,875,698	1,887,963	1,855,691	1,759,898	1,733,722	1,352,281	1,337,064	1,152,105	1,107,882	160,141	93,914	56,263	30,117,000	25,569	0	0	0	0	0	0	0
Intangible Assets	526,821	544,796	627,436	883,600	632,434	475,043	499,318	557,159	636,421	726,914	790,405	853,872	819,487	753,327	752,296	640,309	639,107	118,492	168,480	91,021	44,638	38,319	7,140	7,117	8,722	4,600	1,800	900	0
Inventory	398,385	357,960	327,525	291,181	170,704	162,912	155,927	136,552	136,586	132,276	128,097	135,293	132,236	126,633	130,851	108,563	88,346	64,085	53,653	60,164	65,160	56,113	31,883	28,899	22,498	19,900	14,600	9,900	6,200
Liabilities And Stockholders Equity	6,115,190	6,287,735	6,146,954	5,971,198	5,235,616	5,748,332	5,038,516	4,308,194	4,189,678	4,454,372	4,088,392	4,125,948	3,756,453	3,913,995	3,796,464	2,885,323	2,775,174	1,212,012	765,298	714,599	551,930	454,511	356,968	230,261	148,117	106,700	78,900	66,200	26,200
Long Term Debt	921,824	1,471,898	1,094,144	1,880,210	1,421,108	1,671,090	1,758,258	1,067,096	1,049,026	1,044,965	856,853	861,729	446,005	820,526	898,945	951,109	983,017	501,601	202,548	211,120	114,160	106,840	81,183	22,017	0	0	0	0	0
Long Term Debt Total	0	0	0	0	1,421,108	1,671,090	1,758,258	1,067,096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	23,546	0	15,425	87,052	75,529	53,084	55,726	50,116	44,593	40,687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	943,041	1,130,781	1,061,254	1,429,739	1,082,705	1,015,127	1,100,544	627,916	769,576	779,412	515,180	452,955	368,818	44,599	125,414	644,389	638,470	78,666	17,764	22,715	24,396	65,221	33,265	8,807	21,226	8,100	6,000	6,900	2,400
Net Invested Capital	5,317,558	5,328,061	5,038,320	4,720,588	4,242,943	4,809,176	4,299,254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	515,643	323,750	362,131	439,854	427,236	386,548	368,647	302,039	300,793	294,543	306,584	289,879	249,779	208,338	206,644	179,321	152,542	87,577	71,982	74,279	69,727	57,689	46,238	37,577	22,363	18,000	10,400	7,000	4,700
Net Tangible Assets	0	293,606	118,351	-292,386	-236,346	51,391	28,774	124,419	53,917	34,867	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	1,068,267	1,419,429	592,132	1,052,230	618,903	1,182,871	1,323,181	729,140	693,261	717,124	583,851	694,512	266,775	976,181	957,940	441,180	482,215	566,660	278,586	299,029	163,583	111,554	119,448	97,940	57,213	46,200	38,700	35,900	9,900
Non Current Assets Total	3,967,630	3,893,783	4,037,352	4,329,485	3,665,368	3,593,272	3,390,543	3,270,625	3,228,064	3,305,622	3,167,503	3,131,054	3,008,021	2,549,407	2,462,994	2,181,768	2,127,228	528,821	395,041	327,515	293,069	261,469	179,637	89,745	50,986	32,500	20,400	17,600	8,900
Non Current Liabilities Other	207,401	200,475	209,320	186,724	106,201	89,279	334,668	279,063	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	1,228,133	1,846,601	1,532,934	2,874,343	1,747,680	2,141,173	2,172,728	1,392,669	1,359,371	1,364,747	1,027,483	1,101,203	716,998	1,049,235	1,129,765	1,169,104	1,217,315	529,316	223,170	226,168	121,866	109,992	86,110	23,107	15,537	5,600	5,100	5,800	6,600
Non Currrent Assets Other	26,717	254,395	157,644	423,770	188,380	464,536	349,424	306,357	270,965	258,354	71,282	59,985	56,154	60,953	29,780	25,916	24,620	26,502	25,016	16,272	10,967	8,211	10,328	11,795	4,290	1,500	800	600	100
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	269,588	420,970	468,611	294,931	422,505	330,916	295,567	212,542	218,059	34,718	23,380	45,045	74,640	41,628	89,079	86,189	28,911	31,362	39,802	21,993	18,177	9,373	5,479	0	0	0	0	0
Other Current Assets	175,750	293,976	354,645	182,299	105,464	109,161	106,487	66,799	70,339	113,771	66,290	55,363	90,707	95,133	130,418	35,566	15,138	13,403	37,922	26,113	18,454	22,817	20,238	15,233	8,110	6,200	3,400	1,600	1,100
Other Current Liab	318,468	417,237	505,252	372,598	532,809	354,300	214,871	211,583	165,313	205,193	235,320	220,827	244,980	234,265	259,426	173,506	113,645	-5,274,697	-1,110,179	-2,706,072	-8,027,432	-5,980,447	8,434	1,706	11,297	9,700	7,800	3,900	3,300
Other Liab	0	411,928	438,790	516,401	280,914	451,788	385,567	325,573	293,668	202,518	26,870	43,061	63,881	28,042	18,130	5,406	8,405	6,010	3,052	4,676	7,706	3,152	4,927	541	0	0	0	0	0
Other Stockholder Equity	1,782,092	1,707,827	1,955,448	1,961,414	1,974,670	1,563,644	1,511,349	1,674,820	1,588,599	1,656,246	1,661,089	1,682,501	1,673,637	1,648,739	1,622,879	1,167,890	1,167,100	351,541	279,932	287,262	262,545	208,389	156,965	133,477	75,092	64,100	41,600	40,600	7,500
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Gross	1,281,802	945,743	1,270,599	559,372	1,154,373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Net	870,277	662,170	638,183	528,563	455,243	511,659	494,321	436,655	442,944	428,093	445,044	418,932	371,792	345,664	317,467	289,672	283,491	221,277	195,199	217,108	232,860	211,913	160,365	70,833	37,974	26,400	17,800	16,100	8,800
Property Plant Equipment	0	586,564	638,183	661,894	512,548	511,659	494,321	436,655	442,944	428,093	445,044	418,932	371,792	345,664	317,467	289,672	283,491	221,277	195,199	217,108	232,860	211,913	160,365	70,833	0	0	0	0	0
Retained Earnings	2,456,800	2,160,173	1,465,070	758,533	868,838	1,068,980	1,027,186	929,625	968,353	990,951	1,050,239	1,029,425	855,928	759,890	615,579	477,812	388,779	344,739	274,200	211,975	163,270	120,420	97,278	60,311	38,458	25,800	16,600	7,800	2,500
Retained Earnings Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	587,970	389,552	847,626	42,539	285,244	503,116	200	1,068,095	1,049,948	131,119	850,202	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	1,611,125	1,861,450	1,941,770	2,026,742	1,706,352	2,174,206	1,758,258	1,067,096	1,059,587	1,172,079	845,483	846,992	589,951	873,006	950,971	977,702	985,790	509,023	209,464	219,090	123,389	110,114	89,725	30,341	33,366	14,400	10,300	8,900	7,700
Short Term Debt	610,238	389,552	847,626	65,989	285,244	503,116	1,359	999	922	131,119	207	948	143,946	75,835	53,417	27,984	2,773	7,422	6,916	7,970	9,229	3,274	8,542	8,324	18,153	9,100	5,300	3,200	1,200
Short Term Investments	389,698	687,597	184,785	117,249	129,586	234,606	359,198	92,999	130,817	184,036	49,923	90,451	54,577	106,077	40,000	0	2,313	52,782	15,000	30,153	6,527	11,530	22,512	37,273	32,020	23,800	25,800	28,100	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	6,115,190	6,287,735	6,146,954	5,971,198	5,235,616	5,748,332	5,038,516	4,308,194	4,189,678	4,454,372	4,088,392	4,125,948	3,756,453	3,913,995	3,796,464	2,885,323	2,775,174	1,212,012	765,298	714,599	551,930	454,511	356,968	230,261	148,117	106,700	78,900	66,200	26,200
Total Current Assets	2,147,560	2,393,952	2,109,602	1,641,713	1,570,248	2,155,060	1,647,973	1,037,569	961,614	1,148,750	920,889	994,894	748,432	1,364,588	1,333,470	703,555	647,946	683,191	370,257	387,084	258,861	193,042	177,331	140,516	97,131	74,200	58,500	48,600	17,300
Total Current Liabilities	1,079,293	974,523	1,517,470	613,806	951,345	972,189	324,792	308,429	268,353	431,626	337,038	300,382	481,657	388,407	375,530	262,375	165,731	116,531	91,671	88,055	95,278	81,488	57,883	42,576	39,918	28,000	19,800	12,700	7,400
Total Liab	2,307,426	2,821,124	3,050,404	3,488,149	2,699,025	3,113,362	2,497,520	1,701,098	1,627,724	1,796,373	1,364,521	1,401,585	1,198,655	1,437,642	1,505,295	1,431,479	1,383,046	645,847	314,841	314,223	217,144	191,480	143,993	65,683	55,455	33,600	24,900	18,500	14,000
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	3,807,764	3,466,611	3,096,550	2,483,049	2,536,591	2,634,970	2,540,996	2,607,096	2,559,920	2,649,744	2,714,332	2,714,704	2,548,304	2,476,353	2,291,169	1,453,844	1,391,575	566,165	450,457	400,376	334,786	263,031	212,975	164,385	92,393	73,000	54,000	47,700	12,200
Treasury Stock	0	0	0	0	-111,966	-178,903	-118,987	-120,006	-152,412	-167,190	-116,613	-35,653	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31
Accounts Payable	84,155	76,887	83,939	84,386	98,734	82,836	85,195	87,012	101,224	94,265	103,004	103,471	118,153	90,859	94,850	71,139	84,767	64,816	56,526	63,237	69,415	59,912	60,942	46,501	59,205	50,550	48,500	44,575	51,218	40,874	45,563	38,930	52,306	41,938	42,207	45,074	46,124	42,055	44,183	40,930	50,869	40,098	43,467	40,760	51,311	56,091	60,694	42,099	59,848	44,900	49,573	51,976	47,803	65,067	49,007	45,572	43,775	42,078	38,645	38,978	48,836	41,158	39,354	37,822	40,379	35,409	20,315	23,806	23,806	33,295	22,019	15,934	15,934	14,312	17,417	20,157	20,157	13,369	16,668	14,449	19,481	17,047	18,653	20,670	23,661	18,377	20,453	20,262	20,262	16,615	20,257	17,107	16,658	13,300	13,208	11,467	10,468	8,136	8,000	7,900	9,200	7,500	6,900	5,200	6,700	4,800	4,500	4,700	5,600	-	-	2,600
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Accumulated Other Comprehensive Income	-433,830	-438,687	-417,902	-396,261	-404,091	-440,933	-391,421	-333,822	-326,670	-291,601	-260,966	-266,245	-239,600	-292,934	-351,611	-387,529	-309,619	-353,116	-314,090	-318,604	-310,644	-305,173	-279,644	-205,564	-220,759	-225,580	-244,791	-295,196	-333,839	-249,070	-248,871	-215,995	-259,156	-245,518	-195,842	-235,314	-134,735	-75,079	13,067	7,628	-4,192	1,307	-29,935	20,510	43,991	38,861	9,077	46,563	15,904	9,155	103,404	86,619	64,754	61,674	7,055	30,271	50,146	48,279	24,469	-5,979	15,155	46,657	101,797	102,501	75,024	65,854	48,399	41,235	-131,650	31,299	33,951	16,948	16,948	22,648	19,140	40,675	40,675	24,542	21,550	26,537	29,992	17,508	12,953	8,302	6,586	-1,421	128	-8,878	-42,726	-7,162	-10,931	-7,224	-430	-7,796	-6,109	-5,787	-4,568	-3,557	-5,000	-4,000	-2,400	-3,500	-4,600	-4,900	-4,500	-4,200	-4,400	-3,100	-1,000	-	-	200
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Capital Lease Obligations	22,268	0	0	0	22,220	0	0	0	22,048	0	0	0	23,450	0	0	0	18,739	103,190	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Capital Stock	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Capital Surpluse	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,785,696	1,777,017	1,769,122	1,734,421	1,722,185	1,742,191	1,660,705	1,649,368	1,640,201	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Cash	668,084	579,935	609,549	359,180	730,669	1,271,597	706,534	770,515	880,516	617,541	759,047	787,786	597,003	465,352	688,264	656,819	623,647	700,860	624,616	552,857	1,159,079	599,842	674,413	814,923	657,714	671,751	542,841	245,446	439,180	354,646	328,157	355,785	290,011	330,951	234,330	287,811	392,667	484,210	418,934	564,272	330,303	279,988	299,819	372,757	394,037	258,229	214,008	219,855	221,133	393,850	787,865	776,581	828,407	807,752	844,209	794,770	825,557	861,273	390,311	337,036	333,313	326,034	380,667	351,561	347,320	308,685	380,371	430,357	430,357	491,984	473,457	191,700	191,700	171,192	156,995	196,375	196,375	143,068	107,327	108,774	98,993	75,261	51,639	51,228	44,893	51,786	39,497	56,460	56,460	11,297	17,759	20,262	21,534	25,364	30,618	13,872	12,140	14,342	15,300	10,300	6,300	5,500	5,600	7,400	4,300	3,100	3,600	2,200	2,000	-	-	3,700
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Cash And Short Term Investments	1,057,782	1,015,778	1,331,901	1,287,341	1,418,266	1,886,984	1,310,963	1,229,800	1,065,301	957,318	898,021	791,732	714,252	501,954	744,245	744,684	753,233	799,185	785,960	780,391	1,393,685	920,730	900,187	1,014,192	1,016,912	974,946	608,847	273,389	532,179	464,339	406,439	447,259	420,828	429,529	367,547	392,290	576,703	692,024	654,768	677,973	380,226	355,751	373,198	460,541	484,488	311,313	266,327	275,358	275,710	486,347	953,489	938,927	934,484	887,304	918,209	888,770	865,557	861,273	390,311	337,036	333,313	326,034	380,667	351,561	349,633	308,685	479,671	483,139	0	491,984	483,457	206,700	206,700	211,199	208,754	226,528	226,528	205,434	149,657	115,310	105,520	86,789	63,166	62,753	56,423	63,701	57,630	78,972	0	34,579	53,057	57,577	58,807	62,622	63,271	49,965	44,160	42,505	37,000	34,200	30,100	31,400	30,900	32,800	30,100	29,300	29,000	28,600	30,100	-	-	3,700
Common Stock	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,808	2,801	2,769	2,768	2,761	2,751	2,739	2,738	2,735	2,732	2,724	2,721	2,720	2,715	2,711	2,697	2,228	2,218	2,212	2,205	2,193	2,190	2,175	2,138	1,542	1,535	1,535	1,529	1,526	1,513	1,513	1,509	1,505	1,495	1,495	1,493	1,490	1,489	1,485	1,484	1,479	1,479	1,478	1,477	1,476	1,458	1,458	1,455	1,454	1,451	1,443	1,351	1,347	353	351	350	600	300	300	300	300	300	300	300	300	300	300	-	-	200
Common Stock Shares Outstanding	223,823	223,695	223,601	223,684	230,357	230,084	229,938	230,164	231,777	232,129	231,950	232,309	234,834	235,785	234,027	232,211	231,346	226,520	232,712	233,607	232,357	235,151	233,784	232,533	231,751	232,721	232,681	234,881	230,772	239,297	238,667	238,363	228,361	228,323	228,230	228,594	232,207	232,485	231,727	233,948	235,331	233,427	225,405	232,507	232,805	233,131	231,334	230,037	226,224	229,404	232,058	231,479	224,757	230,126	232,687	232,964	223,608	200,601	196,237	195,643	190,769	197,022	197,865	197,529	188,734	171,329	151,091	144,819	144,819	148,060	147,558	143,377	143,377	144,526	143,924	141,872	141,872	142,664	143,042	143,283	140,977	142,235	141,304	140,707	140,173	140,569	140,512	138,270	138,270	141,345	139,659	139,666	137,324	139,015	139,639	135,970	132,134	135,943	135,296	121,975	102,716	154,074	139,630	125,185	96,296	96,296	91,481	96,296	96,296	96,296	105,926	96,296
Common Stock Total Equity	0	0	0	0	0	0	0	0	0	0	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,702	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,812	2,808	2,801	2,769	2,768	2,761	2,751	2,739	2,738	2,735	2,732	2,724	2,721	2,720	2,715	2,711	2,697	2,228	2,218	2,212	2,205	2,193	2,190	2,175	2,138	1,542	1,535	1,535	1,529	1,526	1,523	1,513	1,509	1,505	1,503	1,495	1,493	1,490	1,489	1,485	1,484	1,479	1,479	1,478	1,477	1,476	1,458	1,458	1,455	1,454	1,451	1,443	1,351	1,347	353	351	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Current Deferred Revenue	66,432	63,400	68,400	71,000	69,000	0	70,242	0	63,368	83,050	22,824	54,423	57,066	43,249	21,872	61,415	48,525	36,441	-7,319	32,850	45,358	1,356	3,325	42,184	49,357	70,143	0	40,495	44,629	7,671	50,984	45,718	49,812	0	2,999	31,680,000	49,190	31,834,000	32,861,000	35,639,000	50,642	31,047,000	29,375,000	2,990	27,296	29,298,000	35,649	33,942	32,883	35,841	31,219	30,809	30,504	17,674	16,356	17,497	18,912	10,256	8,696	6,599	12,049	7,862	6,628	6,739	8,934	3,741	6,066	5,360,000	0	1,971	2,353	1,179,000	1,179,000	11,918	1,732	2,766,000	2,766,000	12,097	7,159	6,147	8,094,000	8,231	10,561	13,452	6,035,000	31,154	29,335	20,645	0	24,032	21,955	19,897	15,888	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Deferred Long Term Liab	0	0	0	0	33,123	0	0	0	28,930	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	76,727	0	0	0	40,621	0	0	0	69,610	0	0	0	117,264	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Good Will	2,475,732	2,434,467	2,456,538	2,454,081	2,352,569	2,299,261	2,341,123	2,346,740	2,350,763	2,353,913	2,332,697	2,335,270	2,389,111	2,313,246	2,134,810	2,102,844	2,140,503	2,115,284	2,117,515	2,114,251	2,108,536	2,116,889	2,101,461	2,020,174	2,012,904	2,009,856	1,995,807	1,969,460	1,925,518	1,962,514	1,971,884	1,898,934	1,875,698	1,846,471	1,872,067	1,862,371	1,887,963	1,833,473	1,882,468	1,864,022	1,855,691	1,865,822	1,791,789	1,756,234	1,759,898	1,758,627	1,752,230	1,743,022	1,733,722	1,658,598	1,370,749	1,364,183	1,352,281	1,348,439	1,316,955	1,328,160	1,337,064	1,273,754	1,169,617	1,148,924	1,152,105	1,134,327	1,116,518	1,113,354	1,107,882	1,113,497	159,013	160,141	160,141	140,411	132,688	100,743	93,914	83,188	81,532	54,165	56,263	46,887	29,719	29,462	30,117,000	28,678	25,008	24,827	25,569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Intangible Assets	526,821	542,604	570,192	585,021	544,796	551,587	594,439	607,738	627,436	638,786	667,273	695,937	883,600	769,902	600,713	603,690	632,434	645,076	680,697	709,361	475,043	504,861	565,378	499,919	499,318	524,672	546,841	559,161	557,159	623,272	593,674	614,113	636,421	635,357	661,437	670,881	726,914	704,710	768,054	761,411	790,405	809,759	798,226	810,359	853,872	886,899	906,763	824,059	819,487	854,199	741,390	752,541	753,327	777,428	713,664	745,800	752,296	693,777	619,380	620,005	640,309	633,173	618,908	631,078	639,107	648,860	132,821	118,492	118,492	106,539	107,948	168,480	168,480	148,555	143,771	91,021	91,021	74,830	43,177	43,420	44,638	42,870	37,765	37,330	38,319	39,367	38,855	7,140	7,140	5,915	6,172	6,544	7,117	7,790	8,050	8,466	8,722	4,087	3,900	4,200	4,600	4,200	1,800	1,800	1,800	900	900	900	900	-	-	0
Inventory	398,385	399,207	391,989	380,824	357,960	323,472	322,831	321,621	327,525	335,691	341,041	316,280	291,181	254,642	202,804	169,340	170,704	168,266	169,520	167,093	162,912	159,968	158,235	160,195	155,927	161,948	155,667	144,033	136,552	144,710	140,090	148,593	136,586	134,074	138,438	136,090	132,276	131,525	135,779	133,412	128,097	143,157	132,646	130,645	135,293	143,173	139,589	134,358	132,236	145,531	139,365	132,752	126,633	131,245	117,808	125,118	130,851	133,618	120,110	110,089	108,563	113,733	107,768	99,095	88,346	86,947	67,237	64,085	64,085	59,315	58,184	53,653	53,653	50,298	49,311	60,164	60,164	57,484	57,757	67,168	65,160	63,650	62,947	61,121	56,113	49,903	46,142	31,883	31,883	32,333	29,817	29,877	28,899	26,390	25,147	22,273	22,498	20,688	17,200	18,000	19,900	18,000	15,900	14,900	14,600	12,400	11,400	10,600	9,900	-	-	6,700
Liabilities And Stockholders Equity	6,115,190	5,906,698	6,347,268	6,278,953	6,287,735	6,516,617	6,153,685	6,184,282	6,146,954	6,043,429	5,907,477	5,762,610	5,971,198	5,771,477	5,294,513	5,180,952	5,235,616	5,142,744	5,382,549	5,420,364	5,748,332	5,299,027	5,309,065	5,105,356	5,038,516	5,096,544	4,556,122	4,067,741	4,308,194	4,328,144	4,118,516	4,119,562	4,189,678	4,159,431	4,131,168	4,170,198	4,454,372	4,461,240	4,563,596	4,486,512	4,088,392	4,055,086	3,976,279	4,033,574	4,125,948	3,956,454	3,876,789	3,798,106	3,756,453	3,948,442	3,998,344	3,958,055	3,913,995	3,890,524	3,767,785	3,780,199	3,796,464	3,754,651	2,970,527	2,832,373	2,885,323	2,872,876	2,873,532	2,842,246	2,775,174	2,695,787	1,261,675	1,212,012	1,212,012	1,173,272	1,149,631	765,298	765,298	740,030	733,039	714,599	714,599	657,598	568,359	555,878	551,930	511,584	485,407	477,015	454,511	442,518	433,257	356,968	356,968	289,661	271,888	251,238	230,261	205,822	192,967	164,453	148,117	135,332	125,600	123,400	106,700	99,500	88,700	83,900	78,900	74,500	70,400	69,900	66,200	-	-	27,400
Long Term Debt	921,824	1,382,359	1,387,937	1,486,706	1,471,898	1,423,206	1,475,255	1,474,902	1,094,144	1,568,656	1,939,713	1,928,951	1,880,210	1,418,320	1,400,179	1,387,316	1,421,108	1,688,762	1,410,557	1,397,553	1,689,358	1,091,953	1,371,196	1,396,872	1,758,258	1,746,994	1,383,830	1,073,763	1,067,096	1,069,440	1,072,412	1,059,787	1,059,587	1,058,416	1,052,971	1,052,423	1,040,960	1,045,948	1,188,953	1,186,282	845,276	863,635	863,429	864,497	846,044	466,221	466,741	468,386	446,005	470,805	822,346	823,465	797,171	822,085	896,136	896,818	870,000	898,797	948,440	948,558	951,109	955,593	982,441	983,182	983,017	983,416	488,971	502,132	501,601	499,890	500,423	203,969	202,548	203,755	204,166	208,352	211,120	213,288	111,208	111,561	114,160	113,578	113,699	110,235	106,840	103,505	99,425	78,838	81,183	30,059	25,747	21,817	22,017	20,816	22,707	16,103	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Long Term Debt Total	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,387,316	1,421,108	1,688,762	1,410,557	1,397,553	1,671,090	1,066,853	1,341,496	1,354,072	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Long Term Investments	0	0	0	0	23,546	0	0	0	0	0	0	0	15,425	0	0	0	87,052	77,458	87,771	61,600	74,329	73,100	76,300	65,300	53,084	53,500	53,800	56,000	55,726	68,200	71,000	0	50,116	0	0	0	44,593	0	0	0	40,687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Net Debt	943,041	903,032	1,278,537	1,520,769	1,130,781	1,017,649	1,228,988	1,173,179	1,061,254	1,322,752	1,180,666	1,141,165	1,429,739	1,322,704	1,017,691	1,055,788	1,082,705	1,164,075	1,139,557	1,195,897	1,015,127	1,168,377	1,088,076	957,056	1,100,544	1,075,243	840,989	826,117	627,916	714,794	744,255	704,002	769,576	727,955	815,256	761,159	779,412	680,166	756,429	607,024	515,180	566,673	546,537	473,952	452,955	408,295	447,115	374,734	368,818	404,316	85,388	96,616	44,599	93,315	106,250	155,428	125,414	90,866	586,192	639,498	644,389	657,570	604,730	634,583	638,470	677,415	122,956	78,666	66,657	15,072	34,188	17,764	17,764	39,594	54,358	22,715	22,715	71,324	6,522	11,605	24,396	40,933	64,649	69,834	65,221	58,353	70,179	33,265	22,802	26,342	14,482	13,813	8,807	3,352	1,118	8,147	21,226	8,596	9,600	15,600	8,100	7,400	3,800	3,800	6,000	6,600	7,300	8,300	6,900	-	-	4,700
Net Invested Capital	5,317,558	5,176,667	5,511,694	5,441,125	5,328,061	5,617,006	5,217,933	5,183,832	5,038,320	4,954,033	4,917,585	4,778,727	4,720,588	4,499,189	4,326,806	4,204,222	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Net Receivables	515,643	326,690	312,599	317,244	323,750	310,975	334,573	372,383	362,131	359,520	366,151	371,694	439,854	437,693	404,631	395,064	427,236	457,517	416,591	384,784	386,548	362,445	357,898	377,757	368,647	329,767	309,881	276,273	302,039	286,482	282,133	284,971	300,793	299,893	293,428	260,452	294,543	307,909	297,781	296,018	306,584	275,921	289,934	284,644	289,879	263,882	248,008	249,994	249,779	225,099	219,496	214,862	208,338	223,241	204,672	202,926	206,644	209,535	182,518	169,261	179,321	185,186	169,962	169,411	152,542	140,814	98,045	87,577	87,577	85,815	82,365	71,982	71,982	68,105	73,777	74,279	74,279	67,491	69,731	72,048	69,727	59,002	58,118	57,831	57,689	53,543	57,149	46,238	46,238	46,545	43,493	41,655	37,577	33,925	30,957	26,291	22,363	22,468	21,900	21,200	18,000	17,300	15,900	13,600	10,400	10,300	9,500	9,600	7,000	-	-	6,100
Net Tangible Assets	0	716,629	596,878	0	293,606	476,912	346,849	285,660	118,351	21,041	-22,098	-181,431	-292,386	-372,015	-478,938	-214,919	-236,346	-292,918	-165,821	-217,556	51,391	-94,447	-142,979	60,447	28,774	32,068	-37,274	-98,817	124,419	0	0	0	53,917	0	0	0	34,867	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Net Working Capital	1,068,267	1,438,019	1,332,978	1,361,074	1,419,429	1,257,975	1,182,193	1,139,968	592,132	958,365	1,299,078	1,166,166	1,052,230	497,074	678,915	582,730	618,903	911,598	704,480	654,819	1,182,871	500,981	746,441	929,417	1,323,181	1,275,997	858,473	489,669	729,140	712,939	652,124	716,775	693,261	699,354	663,399	624,857	717,124	831,644	905,110	902,506	583,851	570,241	604,896	714,734	694,512	264,110	231,815	307,195	266,775	325,528	1,042,638	1,013,370	976,181	956,407	1,030,739	993,471	957,940	996,091	520,799	482,738	441,180	493,151	552,454	525,927	482,215	433,931	576,377	566,660	566,660	576,093	569,385	278,586	278,586	286,179	271,978	299,029	299,029	287,081	202,095	180,011	163,583	145,701	133,703	122,551	111,554	123,589	115,992	119,448	119,448	85,738	95,535	95,901	97,940	101,336	88,644	78,744	57,213	64,776	55,700	49,500	-	-	-	-	-	-	-	-	-	-	-	10,000
Non Current Assets Total	3,967,630	3,944,308	4,035,840	4,027,635	3,893,783	3,761,104	4,008,588	4,087,031	4,037,352	4,015,033	4,105,282	4,097,060	4,329,485	4,183,778	3,658,915	3,601,027	3,665,368	3,600,442	3,768,315	3,821,704	3,593,272	3,429,456	3,621,430	3,360,585	3,390,543	3,525,843	3,396,868	3,304,540	3,270,625	3,365,084	3,217,951	3,156,555	3,228,064	3,182,745	3,203,106	3,212,618	3,305,622	3,193,977	3,362,736	3,270,407	3,167,503	3,181,355	3,074,457	3,049,956	3,131,054	3,153,067	3,132,857	3,038,913	3,008,021	2,974,734	2,590,406	2,569,796	2,549,407	2,538,962	2,415,035	2,448,588	2,462,994	2,382,490	2,185,275	2,127,116	2,181,768	2,164,820	2,138,161	2,146,584	2,127,228	2,074,389	558,462	528,821	0	485,191	472,571	395,041	395,041	377,072	371,622	327,515	327,515	302,270	266,311	284,569	293,069	283,596	276,772	268,655	261,469	250,455	247,319	179,637	0	151,622	124,897	103,487	89,745	66,598	61,281	55,997	50,986	42,245	43,200	42,500	32,500	26,800	20,700	19,800	20,400	19,200	18,700	18,100	17,600	-	-	9,300
Non Current Liabilities Other	207,401	204,664	212,735	221,808	200,475	169,201	175,354	200,813	209,320	196,725	189,286	179,334	186,724	162,676	103,858	95,585	106,201	80,982	182,864	174,572	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Non Current Liabilities Total	1,228,133	1,688,627	1,745,210	1,827,533	1,846,601	1,691,319	1,908,370	1,986,861	1,532,934	1,959,658	2,426,488	2,413,450	2,874,343	1,969,719	1,716,979	1,692,142	1,747,680	2,044,598	1,840,404	1,870,467	2,141,173	1,403,134	1,844,011	1,709,462	2,172,728	2,235,244	1,749,967	1,364,405	1,392,669	1,412,323	1,243,561	1,248,732	1,359,371	1,361,820	1,329,068	1,358,732	1,364,747	1,311,956	1,513,069	1,440,325	1,027,483	1,075,352	1,084,055	1,073,901	1,101,203	705,391	723,017	711,063	716,998	715,739	1,038,817	1,046,871	1,049,235	1,064,900	1,111,231	1,130,994	1,129,765	1,150,272	1,171,460	1,147,415	1,169,104	1,199,835	1,210,917	1,220,852	1,217,315	1,179,854	517,595	529,316	0	532,545	533,336	223,170	223,170	225,642	230,648	226,168	226,168	221,824	118,104	119,432	121,866	116,630	118,470	115,299	109,992	107,243	102,743	86,110	0	39,173	35,825	26,370	23,107	21,337	22,791	16,432	15,537	16,548	18,600	15,400	5,600	5,600	4,900	4,800	5,100	5,200	5,200	5,400	5,800	-	-	6,200
Non Currrent Assets Other	26,717	261,217	302,270	297,478	254,395	130,064	383,592	421,998	157,644	157,118	161,553	158,527	423,770	174,657	166,094	178,741	188,380	120,924	415,978	197,595	464,536	281,592	437,978	294,371	349,424	436,774	322,595	270,527	306,357	311,118	186,110	179,150	270,965	251,978	216,588	261,785	258,354	208,211	245,829	189,282	71,282	70,823	67,488	63,166	59,985	53,246	49,406	59,596	56,154	67,407	67,145	52,072	60,953	46,717	51,833	34,062	29,780	26,728	23,948	26,650	25,916	35,278	31,859	27,463	24,620	27,789	27,541	26,502	26,502	23,572	18,520	25,016	25,016	26,050	21,803	16,272	16,272	18,254	14,709	10,627	10,967	11,810	12,360	11,712	8,211	9,238	8,705	10,328	10,328	9,397	7,727	9,479	11,795	4,795	4,642	4,178	4,290	3,496	3,700	1,500	1,500	1,400	900	800	800	600	900	900	600	-	-	200
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Other Assets	0	220,981	257,589	250,001	269,588	263,407	402,644	459,728	420,970	380,960	483,306	476,584	468,611	547,661	313,878	342,391	292,831	271,113	297,039	365,538	423,705	240,582	386,264	271,255	2,896,222	3,041,445	2,931,321	2,862,691	2,833,970	2,904,575	2,757,614	2,696,924	2,785,120	2,740,838	2,758,234	2,802,920	2,877,529	2,752,419	2,901,879	2,819,793	2,722,459	2,752,819	2,662,038	2,633,960	2,676,078	2,745,537	2,749,042	2,652,517	2,636,229	2,601,114	2,205,139	2,199,841	2,203,743	2,202,216	2,111,654	2,136,164	2,145,527	2,072,275	1,889,273	1,845,676	1,892,096	1,880,604	1,837,121	1,846,987	1,843,737	1,797,680	330,453	322,682	307,544	274,785	263,591	216,968	199,842	182,234	173,700	108,712	110,407	95,700	60,429	58,472	60,209	59,976	52,726	51,497	49,556	50,409	49,364	19,160	19,272	15,312	13,899	16,023	18,912	12,585	12,692	12,644	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Other Current Assets	175,750	220,715	274,939	265,909	293,976	234,082	176,730	173,447	354,645	375,867	196,982	185,844	182,299	393,410	129,014	112,603	105,464	112,190	96,352	106,436	109,161	426,428	271,315	192,627	106,487	104,040	84,859	69,506	66,799	67,529	71,903	82,184	70,339	79,054	92,990	128,381	113,771	103,971	79,671	73,063	66,290	67,855	76,669	81,806	55,363	85,019	90,008	99,483	90,707	116,731	95,588	101,718	95,133	109,772	112,061	114,797	130,418	167,735	92,313	88,871	35,566	83,103	76,974	75,595	15,138	84,952	58,260	13,403	47,317	50,967	53,054	37,922	37,922	33,356	29,575	26,113	26,113	24,919	24,903	16,783	18,454	18,547	24,404	26,655	22,817	24,916	25,017	20,238	20,238	24,582	20,624	18,642	15,233	16,287	12,311	9,927	8,110	7,426	6,300	7,500	6,200	6,000	5,300	2,800	3,400	3,300	1,800	3,000	1,600	-	-	1,600
Other Current Liab	318,468	283,476	325,962	341,615	417,237	548,662	347,200	401,479	505,252	521,079	400,113	395,913	372,598	586,781	534,185	539,350	532,809	395,366	506,931	496,553	354,300	605,956	455,934	308,762	214,871	244,154	252,281	228,957	211,583	209,247	202,878	207,302	165,313	234,904	218,842	-31,392,998	205,193	-31,571,264	-32,609,843	-35,366,745	235,320	-30,783,934	-29,122,268	224,222	220,827	-29,035,917	200,092	226,954	244,980	215,778	207,701	215,772	234,265	233,432	202,325	221,691	259,426	270,394	189,049	148,966	173,506	137,874	133,979	122,212	113,645	145,633	86,099	-5,274,697	85,303	69,556	76,081	-1,110,179	-1,110,179	43,518	63,103	-2,706,072	-2,706,072	41,677	73,485	61,884	-8,027,432	54,393	43,129	40,860	-5,980,447	12,309	9,907	8,434	20,645	4,074	2,750	2,588	1,706	16,688	20,376	12,329	11,297	13,498	12,200	12,900	9,700	12,800	10,900	10,300	7,800	8,800	6,300	7,100	3,900	-	-	3,200
Other Liab	0	256,445	303,111	0	411,928	262,279	433,115	510,042	438,790	386,678	475,848	475,612	516,401	547,441	577,916	304,826	280,914	313,671	375,478	422,756	451,793	311,181	472,815	312,590	337,743	446,658	324,524	250,147	284,952	302,526	120,165	143,227	224,058	199,096	168,153	202,142	206,523	146,965	194,476	120,070	38,447	23,027	31,269	28,772	58,746	38,926	35,849	35,362	63,881	26,413	34,884	32,246	51,397	36,209	13,218	25,061	47,075	13,945	11,615	10,401	5,406	7,132	10,567	10,832	8,405	12,974	6,006	5,770	6,010	4,530	5,370	3,538	3,052	3,954	8,668	7,653	4,676	8,536	6,896	7,871	7,706	3,052	4,771	5,064	3,152	3,738	3,318	4,950	4,927	8,565	9,529	4,004	541	521	513	329	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Other Stockholder Equity	1,782,092	1,768,805	1,755,746	1,739,308	1,707,827	1,693,416	1,680,534	1,657,598	1,628,778	1,636,973	2,082,735	2,039,010	1,472,046	1,729,467	1,708,072	1,689,269	1,665,432	1,607,381	1,572,244	1,579,945	1,563,644	1,508,507	1,533,018	1,540,335	1,511,349	1,500,291	1,505,908	1,481,618	1,674,820	1,638,283	1,623,382	1,602,119	1,588,599	1,580,033	1,578,347	1,566,401	1,656,246	1,676,098	1,650,705	1,649,682	1,661,089	1,668,199	1,659,306	1,651,797	1,682,501	1,713,340	1,702,536	1,691,083	1,673,637	1,674,713	1,770,333	1,745,692	1,648,739	1,704,147	1,644,711	1,659,757	1,622,879	1,654,497	998,961	957,725	1,167,890	1,168,905	1,210,977	1,206,223	1,167,100	1,083,702	366,245	351,541	0	307,106	306,348	279,932	279,932	279,116	272,103	287,262	287,262	262,415	257,833	261,482	262,545	224,156	215,264	210,269	208,389	189,403	190,460	156,965	0	110,388	133,848	133,605	133,477	112,845	99,802	95,520	75,092	55,299	50,800	50,500	49,300	47,100	46,700	42,300	41,600	41,200	41,000	40,700	40,600	-	-	9,300
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Property Plant And Equipment Gross	1,281,802	1,255,052	1,252,481	1,222,979	945,743	1,075,870	0	0	0	0	599,991	563,917	559,372	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Property Plant And Equipment Net	870,277	706,020	706,840	691,055	662,170	590,983	619,192	638,225	638,183	612,114	599,991	563,917	528,563	506,308	475,099	450,701	455,243	491,511	526,020	511,438	511,659	494,024	492,027	503,937	494,321	484,398	465,547	441,849	436,655	460,509	460,337	459,631	442,944	441,907	444,872	409,698	428,093	441,558	460,857	450,614	445,044	428,536	412,419	415,996	418,932	407,530	383,815	386,396	371,792	373,620	385,267	369,955	345,664	336,746	303,381	312,424	317,467	310,215	296,002	281,440	289,672	284,216	301,040	299,597	283,491	276,709	228,009	221,277	0	210,406	208,980	195,199	195,199	194,838	197,922	217,108	217,108	206,570	205,882	226,097	232,860	223,620	224,046	217,158	211,913	200,046	197,955	160,365	0	136,310	110,998	87,464	70,833	54,013	48,589	43,353	37,974	34,662	35,600	36,800	26,400	21,200	18,000	17,200	17,800	17,700	16,900	16,300	16,100	-	-	9,100
Property Plant Equipment	0	706,020	706,840	0	586,564	590,983	619,192	638,225	638,183	612,114	599,991	563,917	661,894	506,308	416,409	450,701	512,548	491,511	585,293	567,754	511,659	494,024	492,027	503,937	494,321	484,398	465,547	441,849	436,655	460,509	460,337	459,631	442,944	441,907	444,872	409,698	428,093	441,558	460,857	450,614	445,044	428,536	412,419	415,996	418,932	407,530	383,815	386,396	371,792	373,620	385,267	369,955	345,664	336,746	303,381	312,424	317,467	310,215	296,002	281,440	289,672	284,216	301,040	299,597	283,491	276,709	228,009	224,124	221,277	210,406	208,980	200,211	195,199	194,838	197,922	209,016	217,108	206,570	205,882	226,097	232,860	223,620	224,046	217,158	211,913	200,046	197,955	175,194	160,365	136,310	110,998	87,464	70,833	54,013	48,589	43,353	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Retained Earnings	2,456,800	1,922,193	1,865,160	1,819,166	2,160,173	2,072,575	1,990,596	1,913,660	1,465,070	1,665,666	1,537,485	1,430,528	758,533	1,271,964	1,262,077	1,187,644	868,838	1,210,359	1,371,445	1,342,409	1,068,980	1,321,094	1,268,140	1,243,503	1,027,186	1,289,603	1,241,764	1,240,484	929,625	1,273,605	1,243,888	1,235,667	968,353	1,181,136	1,148,549	1,136,971	990,951	1,101,396	1,079,250	1,063,190	1,050,239	994,357	953,656	1,005,417	1,029,425	947,015	917,852	884,520	855,928	856,304	821,159	787,871	759,890	723,601	687,112	648,593	615,579	571,115	533,425	502,496	477,812	453,129	432,338	409,112	388,779	373,779	381,107	344,739	344,739	325,292	305,934	274,200	274,200	257,340	239,700	211,975	211,975	196,133	183,493	174,691	163,270	154,283	142,518	131,415	120,420	118,647	111,358	97,278	97,278	86,344	80,151	68,808	60,311	53,727	47,246	43,681	38,458	38,100	33,600	29,600	25,800	22,200	19,000	19,400	16,600	13,700	11,700	9,700	7,800	-	-	3,400
Retained Earnings Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Short Long Term Debt	587,970	100,608	500,149	393,243	389,552	866,040	460,267	468,792	847,626	371,637	0	0	42,539	369,736	305,776	325,291	285,244	72,983	353,616	351,201	503,616	701,366	420,993	417,907	200	1,769,994	1,396,330	1,073,763	1,068,095	1,075,840	1,072,000	0	1,049,948	0	0	0	131,119	0	0	0	850,202	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Short Long Term Debt Total	1,611,125	1,482,967	1,888,086	1,879,949	1,861,450	2,289,246	1,935,522	1,943,694	1,941,770	1,940,293	1,939,713	1,928,951	2,026,742	1,788,056	1,705,955	1,712,607	1,706,352	1,864,935	1,764,173	1,748,754	2,174,206	1,768,219	1,762,489	1,771,979	1,758,258	1,746,994	1,383,830	1,071,563	1,067,096	1,069,440	1,072,412	1,059,787	1,059,587	1,058,906	1,049,586	1,048,970	1,172,079	1,164,376	1,175,363	1,171,296	845,483	846,661	846,356	846,709	846,992	666,524	661,123	594,589	589,951	798,166	873,253	873,197	873,006	901,067	950,459	950,198	950,971	952,139	976,503	976,534	977,702	983,604	985,397	986,144	985,790	986,100	503,327	509,023	497,014	507,056	507,645	209,464	209,464	210,786	211,353	219,090	219,090	214,392	113,849	120,379	123,389	116,194	116,288	121,062	110,114	110,139	109,676	89,725	79,262	37,639	32,241	34,075	30,341	28,716	31,736	22,019	33,366	22,938	24,900	25,900	14,400	12,900	9,400	11,200	10,300	9,700	10,900	10,500	8,900	-	-	8,400
Short Term Debt	610,238	100,608	500,149	393,243	389,552	866,040	460,267	468,792	847,626	371,637	-22,824	-54,423	65,989	369,736	305,776	325,291	285,244	134,081	353,616	351,201	503,116	701,366	420,993	417,907	1,359	-70,143	1,396,330	-40,495	999	-7,671	-50,984	-45,718	922	490	615	647	131,119	130,828	410	414	207	326	727	912	948	221,103	215,682	149,003	143,946	351,661	76,807	76,332	75,835	78,982	54,323	53,380	53,417	53,342	28,063	27,976	27,984	28,011	2,956	2,962	2,773	2,684	14,356	7,422	7,422	7,166	7,222	6,916	6,916	7,031	7,187	7,970	7,970	1,104	2,641	8,818	9,229	2,616	2,589	10,827	3,274	6,634	10,251	8,542	8,542	7,580	6,494	12,258	8,324	7,900	9,458	5,916	18,153	6,677	6,500	10,600	9,100	7,400	4,600	6,500	5,300	4,700	5,800	5,100	3,200	-	-	2,300
Short Term Investments	389,698	435,843	722,352	928,161	687,597	615,387	604,429	459,285	184,785	339,777	138,974	3,946	117,249	36,602	55,981	87,865	129,586	98,325	161,344	227,534	234,606	320,888	225,774	199,269	359,198	303,195	66,006	27,943	92,999	109,693	78,282	91,474	130,817	98,578	133,217	104,479	184,036	207,814	235,834	113,701	49,923	75,763	73,379	87,784	90,451	53,084	52,319	55,503	54,577	92,497	165,624	162,346	106,077	79,552	74,000	94,000	40,000	0	0	0	0	0	0	0	2,313	0	99,300	52,782	52,782	0	10,000	15,000	15,000	40,007	51,759	30,153	30,153	62,366	42,330	6,536	6,527	11,528	11,527	11,525	11,530	11,915	18,133	22,512	22,512	23,282	35,298	37,315	37,273	37,258	32,653	36,093	32,020	28,163	21,700	23,900	23,800	25,900	25,300	25,400	25,800	26,200	25,400	26,400	28,100	-	-	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Total Assets	6,115,190	5,906,698	6,347,268	6,278,953	6,287,735	6,516,617	6,153,685	6,184,282	6,146,954	6,043,429	5,907,477	5,762,610	5,971,198	5,771,477	5,294,513	5,180,952	5,235,616	5,142,744	5,382,549	5,420,364	5,748,332	5,299,027	5,309,065	5,105,356	5,038,516	5,096,544	4,556,122	4,067,741	4,308,194	4,328,144	4,118,516	4,119,562	4,189,678	4,159,431	4,131,168	4,170,198	4,454,372	4,461,240	4,563,596	4,486,512	4,088,392	4,055,086	3,976,279	4,033,574	4,125,948	3,956,454	3,876,789	3,798,106	3,756,453	3,948,442	3,998,344	3,958,055	3,913,995	3,890,524	3,767,785	3,780,199	3,796,464	3,754,651	2,970,527	2,832,373	2,885,323	2,872,876	2,873,532	2,842,246	2,775,174	2,695,787	1,261,675	1,212,012	1,212,012	1,173,272	1,149,631	765,298	765,298	740,030	733,039	714,599	714,599	657,598	568,359	555,878	551,930	511,584	485,407	477,015	454,511	442,518	433,257	356,968	356,968	289,661	271,888	251,238	230,261	205,822	192,967	164,453	148,117	135,332	125,600	123,400	106,700	99,500	88,700	83,900	78,900	74,500	70,400	69,900	66,200	-	-	27,400
Total Current Assets	2,147,560	1,962,390	2,311,428	2,251,318	2,393,952	2,755,513	2,145,097	2,097,251	2,109,602	2,028,396	1,802,195	1,665,550	1,641,713	1,587,699	1,635,598	1,579,925	1,570,248	1,542,302	1,614,234	1,598,660	2,155,060	1,869,571	1,687,635	1,744,771	1,647,973	1,570,701	1,159,254	763,201	1,037,569	963,060	900,565	963,007	961,614	976,686	928,062	957,580	1,148,750	1,267,263	1,200,860	1,216,105	920,889	873,731	901,822	983,618	994,894	803,387	743,932	759,193	748,432	973,708	1,407,938	1,388,259	1,364,588	1,351,562	1,352,750	1,331,611	1,333,470	1,372,161	785,252	705,257	703,555	708,056	735,371	695,662	647,946	621,398	703,213	683,191	683,191	688,081	677,060	370,257	370,257	362,958	361,417	387,084	387,084	355,328	302,048	271,309	258,861	227,988	208,635	208,360	193,042	192,063	185,938	177,331	177,331	138,039	146,991	147,751	140,516	139,224	131,686	108,456	97,131	93,087	82,400	80,900	74,200	72,700	68,000	64,100	58,500	55,300	51,700	51,800	48,600	-	-	18,100
Total Current Liabilities	1,079,293	524,371	978,450	890,244	974,523	1,497,538	962,904	957,283	1,517,470	1,070,031	503,117	499,384	613,806	1,090,625	956,683	997,195	951,345	630,704	909,754	943,841	972,189	1,368,590	941,194	815,354	324,792	294,704	300,781	273,532	308,429	250,121	248,441	246,232	268,353	277,332	264,663	332,723	431,626	435,619	295,750	313,599	337,038	303,490	296,926	268,884	300,382	539,277	512,117	451,998	481,657	648,180	365,300	374,889	388,407	395,155	322,011	338,140	375,530	376,070	264,453	222,519	262,375	214,905	182,917	169,735	165,731	187,467	126,836	116,531	116,531	111,988	107,675	91,671	91,671	76,779	89,439	88,055	88,055	68,247	99,953	91,298	95,278	82,287	74,932	85,809	81,488	68,474	69,946	57,883	57,883	52,301	51,456	51,850	42,576	37,888	43,042	29,712	39,918	28,311	26,700	31,400	28,000	27,700	22,400	22,000	19,800	18,300	16,600	16,900	12,700	-	-	8,100
Total Liab	2,307,426	2,212,998	2,723,660	2,717,777	2,821,124	3,188,857	2,871,274	2,944,144	3,050,404	3,029,689	2,929,605	2,912,834	3,488,149	3,060,344	2,673,662	2,689,337	2,699,025	2,675,302	2,750,158	2,814,308	3,113,362	2,771,724	2,785,205	2,524,816	2,497,520	2,529,948	2,050,748	1,637,937	1,701,098	1,662,444	1,492,002	1,494,964	1,627,724	1,639,152	1,593,731	1,691,455	1,796,373	1,747,575	1,808,819	1,753,924	1,364,521	1,378,842	1,380,981	1,342,785	1,401,585	1,244,668	1,235,134	1,163,061	1,198,655	1,363,919	1,404,117	1,421,760	1,437,642	1,460,055	1,433,242	1,469,134	1,505,295	1,526,342	1,435,913	1,369,934	1,431,479	1,414,740	1,393,834	1,390,587	1,383,046	1,367,321	644,431	645,847	645,847	644,533	641,011	314,841	314,841	302,421	320,087	314,223	314,223	290,071	218,057	210,730	217,144	198,917	193,402	201,108	191,480	175,717	172,689	143,993	143,993	91,474	87,281	78,220	65,683	59,225	65,833	46,144	55,455	44,859	45,300	46,800	33,600	33,300	27,300	26,800	24,900	23,500	21,800	22,300	18,500	-	-	14,300
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Total Stockholder Equity	3,807,764	3,693,700	3,623,608	3,561,176	3,466,611	3,327,760	3,282,411	3,240,138	3,096,550	3,013,740	2,977,872	2,849,776	2,483,049	2,711,133	2,620,851	2,491,615	2,536,591	2,467,442	2,632,391	2,606,056	2,634,970	2,527,303	2,523,860	2,580,540	2,540,996	2,566,596	2,505,374	2,429,804	2,607,096	2,665,700	2,621,082	2,624,598	2,559,920	2,517,981	2,533,708	2,471,184	2,649,744	2,705,306	2,745,767	2,723,684	2,714,332	2,666,368	2,585,770	2,681,015	2,714,704	2,702,123	2,632,149	2,625,354	2,548,304	2,542,755	2,594,227	2,536,295	2,476,353	2,430,469	2,334,543	2,311,065	2,291,169	2,228,309	1,534,614	1,462,439	1,453,844	1,457,760	1,479,029	1,451,046	1,391,575	1,327,969	617,244	566,165	566,165	528,739	508,620	450,457	450,457	437,609	412,952	400,376	400,376	367,527	350,302	345,148	334,786	312,667	292,005	275,907	263,031	266,801	260,568	212,975	212,975	198,187	184,607	173,018	164,385	146,415	126,887	118,046	92,393	90,192	80,000	76,400	73,000	66,100	61,400	57,100	54,000	51,000	48,600	47,600	47,700	-	-	13,100
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-96,898	-111,966	-161,625	-162,087	-142,636	-178,903	-152,025	-116,706	-100,302	-118,987	-123,474	-63,705	-77,489	-120,006	-126,300	-131,868	-145,029	-152,412	-155,810	-154,213	-155,216	-167,190	-135,779	-150,853	-142,691	-116,613	-102,717	-98,993	-96,435	-35,653	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31
Begin Period Cash Flow	730,669	880,516	597,984	628,229	1,159,079	657,714	439,180	290,011	392,667	330,303	394,037	221,133	828,407	825,557	333,313	347,320	430,357	191,700	196,375	98,993	44,893	56,460	24,008	12,393	6,343	4,300	2,000	5,300	3,600
Capital Expenditures	162,802	149,336	206,534	304,237	274,884	150,763	124,405	93,924	117,481	97,003	118,693	128,085	121,388	123,909	69,357	57,917	58,614	35,353	13,728	12,621	19,558	59,136	102,067	39,445	11,811	10,500	6,800	9,700	1,700
Cash And Cash Equivalents Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	-62,585	-149,847	282,532	-31,226	-529,689	501,365	218,534	149,169	-102,656	62,364	-63,734	172,904	-607,274	2,850	492,244	-14,007	-83,037	238,657	-4,675	97,382	54,100	-11,567	32,452	9,141	5,797	2,000	2,300	-3,300	1,700
Change In Working Capital	-186,958	-31,881	-130,012	16,801	-44,324	-95,159	-67,231	10,287	-81,110	-78,809	5,665	-83,868	-42,917	-15,899	-34,797	-18,072	-55,826	-5,083	-3,753	-20,014	-25,141	-14,312	-5,853	-11,967	1,024	-6,300	-4,700	-4,200	-900
Change Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-55,119	15,451	-7,402	-14,711	-39,578	-41,813	-34,165	-12,238	-24,764	-16,561	-14,921	-14,289	-28,203	-6,884	-25,213	-19,078	1,807,000	378,000	54,000	128,000	1,749,000	631,000	0	0	0	0	0	0	0
Change To Inventory	-44,787	-61,950	-81,803	-107,573	-30,028	-36,918	-21,633	-20,346	-33,194	-41,792	-17,499	-20,376	-15,945	2,348	-21,534	-30,371	-8,738	-4,202	3,764	2,019	-6,396	-18,183	-3,926	-6,587	-3,698	-3,200	-6,000	-4,200	-1,800
Change To Liabilities	0	-1,756	-5,975	8,442	9,252	6,993	4,321	-1,466	7,732	-5,495	0	0	0	0	0	0	0	0	0	3,049	0	2,731	7,262	12,020	0	0	0	0	0
Change To Netincome	0	-95,023	41,483	-76,447	144,401	22,302	93,020	19,397	4,364	16,034	23,829	0	0	0	0	0	7,534	525	5,592	0	0	9,778	6,995	323	0	0	0	0	0
Change To Operating Activities	0	68,122	-130,012	36,893	22,812	-37,660	4,887	28,861	26,025	-30,995	21,139	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	205,336	208,397	214,931	209,971	231,458	206,436	216,448	213,056	191,473	200,782	199,355	197,892	167,377	142,779	120,394	105,704	62,583	30,038	24,955	22,961	25,788	24,709	15,059	10,455	7,831	5,800	4,900	2,500	1,800
Dividends Paid	0	25,357	0	622,200	0	567,285	769,662	0	0	785,867	13	400,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	668,084	730,669	880,516	597,003	629,390	1,159,079	657,714	439,180	290,011	392,667	330,303	394,037	221,133	828,407	825,557	333,313	347,320	430,357	191,700	196,375	98,993	44,893	56,460	21,534	12,140	6,300	4,300	2,000	5,300
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	296,653	565,928	432,467	188,035	55,959	208,733	162,374	247,678	200,016	190,962	140,264	116,795	123,391	126,843	147,638	115,081	26,197	66,126	77,509	41,177	44,502	-22,450	-43,980	-573	14,365	1,100	1,700	-5,600	2,200
Investments	-153,727	-726,763	-40,735	-443,281	-222,278	-211,356	-464,264	-179,056	44,091	-153,805	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	177	122	7,919	7,662	2,075	4,412	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	-135,393	-41,345	-35,552	-640,163	493,571	722,864	-8,060	-252,947	325,338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	341,303	423,211	512,599	73,640	-41,455	190,380	40,394	80,303	126,857	117,202	69,098	129,537	94,949	144,311	137,767	89,033	50,122	70,539	62,225	48,705	42,850	23,142	34,419	20,106	12,617	12,400	8,800	5,300	2,400
Other Cashflows From Financing Activities	-70,752	404,792	-16,953	1,220,949	-60,305	1,029,274	1,213,146	-8,813	4,923	1,485,097	-103	796,460	154,152	6,793	6,697	-5,686	451,772	292,154	-5,004	90,491	-3,997	3,793	62,156	-5,917	930	900	2,500	800	-1,200
Other Cashflows From Investing Activities	0	-9,774	44,843	-58,408	22,695	-18,520	-23,017	-8,800	-28,719	3,608	0	0	0	0	0	0	0	0	0	0	0	0	617	184	0	0	0	0	0
Other Non Cash Items	41,943	75,633	8,380	165,180	174,633	40,998	23,175	75,642	89,906	47,893	14,990	-1,270	37,692	-14,089	-5,506	4,236	-8,952,414	-325,225	10,012	12,620	8,380	-1,880	16,251	25,656	6,236	100	400	100	100
Sale Purchase Of Stock	0	-25,357	-99,987	-63,995	-74,450	-104,685	-60,970	0	-20,818	-126,889	-86,029	-35,653	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock Based Compensation	47,100	49,507	38,391	40,936	65,893	40,113	34,442	28,288	27,565	42,188	37,935	25,356	19,539	13,592	9,747	9,791	8,982,000	326,000	0	0	0	0	0	0	0	600	0	0	200
Total Cash From Financing Activities	-433,827	-125,803	-150,366	-74,320	-639,080	360,408	387,187	-10,604	-258,613	192,843	-68,759	226,604	-310,630	-35,228	629,198	12,769	494,054	303,160	2,955	95,623	-1,884	6,123	66,245	14,840	3,595	1,800	3,200	31,900	-1,200
Total Cash From Operating Activities	459,455	715,264	639,001	492,272	330,843	359,496	286,779	341,602	317,497	287,965	258,957	244,880	244,779	250,752	216,995	172,998	84,811	101,479	91,237	53,798	64,060	36,686	58,087	38,872	26,176	11,600	8,500	4,100	3,900
Total Cashflows From Investing Activities	0	-735,584	-202,426	-443,281	-222,278	-211,356	-464,264	-179,056	-146,200	-407,601	-251,735	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1996-03-31
Begin Period Cash Flow	579,935	609,549	359,180	730,669	1,271,597	706,534	770,515	880,516	617,541	759,047	787,786	597,984	469,291	692,206	661,776	629,390	700,860	624,616	552,857	1,159,079	599,842	674,413	814,923	657,714	671,751	542,841	245,446	439,180	354,646	328,157	355,785	290,011	330,951	234,330	287,811	392,667	484,210	418,934	564,272	330,303	279,988	299,819	372,757	394,037	258,229	214,008	219,855	221,133	393,850	787,865	776,581	828,407	807,752	844,209	794,770	825,557	861,273	390,311	337,036	333,313	326,034	380,667	351,561	347,320	308,685	380,371	386,070	491,984	491,984	473,457	197,738	171,192	171,192	156,995	210,314	143,068	143,068	107,327	108,774	98,993	75,261	51,639	51,228	44,893	51,786	39,497	42,949	11,297	11,297	17,759	20,262	24,008	25,364	30,618	13,872	12,140	14,342	15,300	10,300	6,300	5,300
Capital Expenditures	52,222	41,043	31,128	38,409	46,591	26,721	37,609	38,415	54,003	51,277	46,295	54,959	66,640	87,721	121,950	27,926	50,288	35,803	36,005	152,788	47,715	36,640	32,310	34,098	32,901	35,481	31,617	24,406	26,384	20,533	25,956	21,051	35,366	25,311	31,812	24,992	29,541	19,814	28,417	19,231	40,797	28,538	26,661	22,697	42,598	38,530	23,735	23,222	49,024	25,840	20,103	26,421	26,939	35,786	37,661	23,523	18,695	24,002	14,974	11,686	20,557	17,153	9,922	10,285	15,091	10,117	11,965	12,607	12,607	9,588	6,924	5,519	5,519	2,602	2,681	3,585	3,585	2,657	3,570	2,809	3,168	4,002	5,761	6,627	11,584	7,805	19,168	28,789	28,789	24,859	29,135	19,284	17,589	10,238	4,732	6,886	4,838	2,173	1,900	2,900	1,100
Cash And Cash Equivalents Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	88,149	-29,614	250,369	-371,489	-540,928	565,063	-63,981	-110,001	262,975	-141,506	-28,739	189,802	128,693	-222,915	30,430	32,386	-71,470	76,244	71,759	-606,222	559,237	-74,571	-140,510	157,209	-14,037	128,910	297,395	-193,734	84,534	26,489	-27,628	65,774	-40,940	96,621	-53,481	-104,856	-91,543	65,276	-145,338	233,969	50,315	-19,831	-72,938	-21,280	135,808	44,221	-5,847	-1,278	-172,717	-394,015	11,284	-51,826	20,655	-36,457	49,439	-30,787	-35,716	470,962	53,275	3,723	7,279	-54,633	29,106	4,241	38,635	-71,686	-5,699	-61,627	-61,627	18,527	275,719	20,508	20,508	14,197	-53,319	53,307	53,307	35,741	-1,447	9,781	23,732	23,622	411	6,335	-6,893	12,289	-3,452	45,163	45,163	-6,462	-2,503	-3,746	-3,830	-5,254	16,746	1,732	-2,202	-958	5,000	4,000	-1,600
Change In Working Capital	-40,519	-28,786	-43,501	-74,152	-79,517	67,223	3,788	-23,375	-17,455	-27,437	-45,299	-39,821	78,385	-38,590	-14,145	-97,917	33,992	17,280	-29,999	-65,597	-3,061	-45,714	6,548	-52,932	-16,272	-30,968	-15,905	-24,711	18,608	-8,386	21,669	-21,604	50,869	-12,704	-26,798	-35,656	28,533	-55,981	-17,077	-34,284	14,328	9,740	-5,132	-13,271	-32,119	17,621	-15,082	-54,288	3,938	-12,175	-18,585	-16,095	10,320	26,295	-17,705	-34,809	-31,396	7,240	27,179	-37,820	45,875	-23,012	-17,128	-23,807	-35,652	3,282	-15,905	1,707	1,707	890	-5,423	548	548	-3,335	3,208	2,228	2,228	-23,575	2,480	-1,147	-10,221	6,495	-6,886	-14,529	5,033	-2,264	-6,754	768	768	-7,876	1,833	-578	9,518	-23,881	884	1,512	335	889	500	-700	-3,000
Change Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-46,080	-16,694	-227	7,882	-696	14,172	17,823	-15,848	-12,541	1,058	7,260	-3,179	-5,695	-537	-8,582	103	-23,542	255	-23,274	6,983	-32,696	-10,204	1,356	-269	-33,957	-13,688	-20,800	34,280	-31,288	-6,670	3,094	22,626	-29,985	-4,671	-10,775	20,667	-9,480	-20,176	-2,025	15,120	-30,847	18,525	-3,624	1,025	-19,104	131	2,338	2,346	-20,057	-3,589	-4,078	-479	-1,993	722	-5,906	293	-13,438	-5,098	-1,731	-4,946	-19,078	0	0	264	1,807,000	0	0	378,000	0	0	1,110	54,000	54,000	374	0	128,000	128,000	104	0	50	1,749,000	0	1,139	243	631,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Inventory	14,043	-17,816	-18,343	-22,671	-17,182	-20,891	-20,091	-3,786	-6,190	-6,749	-24,883	-43,981	-29,796	-29,651	-35,455	-12,671	-7,332	-7,024	-5,281	-10,391	-6,579	-10,995	-14,221	-5,123	2,218	-5,101	-9,972	-8,778	-6,744	-7,797	2,897	-8,702	-8,202	-6,260	-1,543	-17,189	-14,888	-12,737	-6,904	-7,263	11,231	-10,131	-15,728	-2,871	1,796	3,755	-22,466	-3,461	9,558	-13,509	-7,957	-4,037	4,690	-3,309	-294	1,261	-3,677	-7,252	-5,539	-5,066	2,655	-12,761	-10,725	-9,540	-1,529	-4,426	-624	-1,973	-1,973	-1,402	-785	-2,647	-2,647	-1,022	3,620	1,003	1,003	892	3,019	-2,895	-1,662	221	-1,304	-3,651	-5,400	-3,881	-4,718	-234	-234	-858	-559	-2,275	-785	-2,799	-2,439	-564	-1,845	-2,953	300	800	-700
Change To Liabilities	0	-986	-3,056	0	8,947	-2,250	3,214	-11,667	13,676	-2,427	-5,651	-5,598	15,938	-6,299	10,824	-12,021	30,597	-10,745	-5,285	-5,315	7,724	-724	17,485	-17,492	4,321	970	4,924	-9,328	-1,466	0	0	0	7,732	0	0	0	-5,495	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,388	0	5,389	0	0	0	0	0	0	0	0	3,049	0	3,578	0	0	0	0	0	2,731	0	0	0	7,262	0	0	0	12,020	0	0	3,012	0	0	0	0	0
Change To Netincome	0	17,101	14,432	14,432	-125,116	3,174	12,733	14,186	59,721	-11,455	17,515	-24,298	-89,467	-7,136	4,354	15,802	-32,114	171,152	-4,071	9,434	-7,352	10,702	11,462	7,490	93,020	5,507	9,482	7,268	19,397	0	0	0	4,364	0	0	0	16,034	0	0	0	23,829	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11,437	7,534	5,544	1,163	3,075	525	689	0	2,063	5,592	1,238	76	100	0	0	12,053	5,835	0	1,336	0	0	9,778	0	0	0	6,995	0	0	0	323	1,784	0	4,252	0	0	0	0	0
Change To Operating Activities	0	236	-10,280	-10,280	56,204	39,008	-22,670	-4,420	-98,085	26,574	-30,730	-27,771	95,024	17,691	14,435	-90,257	-32,838	95,570	488	-40,408	10,618	-28,569	5,934	-25,643	4,887	-10,162	23,127	-29,644	28,861	15,200	9,000	0	26,025	0	0	0	-30,995	0	0	0	21,139	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	51,570	50,569	51,136	52,061	54,672	50,317	50,410	52,998	51,101	53,161	55,082	55,587	57,170	50,828	48,540	48,476	52,964	56,869	62,365	59,260	49,972	48,855	54,695	52,914	52,820	52,280	56,595	54,753	56,361	53,406	52,485	50,804	51,807	49,479	44,061	46,126	51,099	51,317	49,244	49,122	54,259	50,431	49,580	45,085	54,316	50,141	48,202	45,233	46,779	42,957	38,950	38,691	38,404	35,594	34,840	33,941	33,811	30,374	28,843	27,366	26,975	28,052	25,247	25,430	24,675	19,784	9,388	8,073	8,073	7,902	7,343	6,169	6,169	6,286	6,482	4,836	4,836	5,169	6,060	6,896	6,846	6,533	6,542	5,867	6,664	6,357	7,108	3,669	3,669	4,077	3,747	3,566	3,388	2,111	2,676	2,280	1,898	2,033	2,000	1,900	600
Dividends Paid	0	0	0	0	505	363,284	0	0	41,345	0	0	0	438,301	0	0	0	74,450	0	0	0	567,285	0	0	0	307,144	471,736	0	243,945	0	0	0	0	20,818	0	0	0	0	1,015	4,650	792,119	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	668,084	579,935	609,549	359,180	730,669	1,271,597	706,534	770,515	880,516	617,541	759,047	787,786	597,984	469,291	692,206	661,776	629,390	700,860	624,616	552,857	1,159,079	599,842	674,413	814,923	657,714	671,751	542,841	245,446	439,180	354,646	328,157	355,785	290,011	330,951	234,330	287,811	392,667	484,210	418,934	564,272	330,303	279,988	299,819	372,757	394,037	258,229	214,008	219,855	221,133	393,850	787,865	776,581	828,407	807,752	844,209	794,770	825,557	861,273	390,311	337,036	333,313	326,034	380,667	351,561	347,320	308,685	380,371	430,357	430,357	491,984	473,457	191,700	191,700	171,192	156,995	196,375	196,375	143,068	107,327	108,774	98,993	75,261	51,639	51,228	44,893	51,786	39,497	56,460	56,460	11,297	17,759	20,262	21,534	25,364	30,618	13,872	12,140	14,342	15,300	10,300	3,700
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	99,146	83,641	80,349	33,517	77,728	184,861	134,344	168,995	144,455	104,240	110,104	73,668	203,072	-50,222	12,732	-12,013	59,142	58,394	46,477	-108,054	62,795	46,108	85,713	14,117	43,165	45,716	37,742	35,751	73,639	73,278	73,121	27,640	51,396	70,751	40,018	37,851	49,476	69,920	45,187	26,379	41,390	54,400	21,296	23,178	27,316	36,397	65,181	-12,099	30,655	33,200	35,914	23,622	58,884	52,663	9,265	6,031	33,969	52,882	58,699	2,088	67,967	14,323	37,398	-4,607	7,024	17,464	1,970	19,345	19,345	14,063	16,624	20,849	20,849	16,632	22,237	20,104	20,104	-11,394	22,883	9,584	15,153	22,646	8,722	-2,019	-2,770	5,680	-13,592	-8,505	-8,505	-19,410	-9,312	-6,753	7,584	-13,174	4,242	775	2,460	4,705	5,100	2,100	-2,700
Investments	-58,454	248,369	156,277	-433,847	-124,526	-17,227	-151,884	-277,437	151,924	-172,298	-136,388	116,027	-54,502	-321,889	-80,009	13,119	-80,710	-13,217	42,245	-170,596	83,368	-88,789	-39,201	158,987	-266,335	-235,488	-32,802	61,243	14,095	0	0	0	44,091	0	0	0	-153,805	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	88	75	15	1	77	29	54	5,151	204	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	-436,762	-436,762	-436,762	-506,845	371,452	371,452	371,452	371,452	0	0	-41,345	-60,464	70,135	-45,223	-45,223	-206,763	-206,763	-206,763	-433,400	494,554	-326	-308	-349	722,864	425,826	299,838	-357	-8,060	0	0	0	-252,947	0	0	0	325,338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	97,664	77,818	80,786	85,035	88,844	82,394	96,661	155,312	129,186	133,139	121,051	129,223	212,685	16,910	89,764	39,829	44,933	-160,636	44,728	29,520	60,950	60,319	36,816	32,295	-39,693	48,485	13,951	17,651	10,758	33,707	21,002	14,836	48,373	34,014	25,106	19,364	26,049	34,814	33,056	23,283	59,987	40,776	-51,738	20,073	38,284	29,081	33,682	28,490	-787	35,145	33,288	27,981	36,289	36,488	38,520	33,014	44,464	37,690	30,929	24,684	24,683	20,791	23,226	20,333	15,000	-7,328	22,583	19,447	19,447	19,358	14,154	16,860	16,860	17,640	13,777	15,842	15,842	12,640	8,802	11,421	8,987	11,765	11,103	10,995	1,773	7,289	4,574	10,934	10,934	6,193	11,335	5,957	6,584	6,481	1,818	5,223	358	4,459	4,000	3,800	1,000
Other Cashflows From Financing Activities	-44,198	3,568	-3,036	-9,903	-65,375	1,150,924	23,130	-10,687	69,362	-81,070	-2,830	-2,017	908,602	59,396	6,073	4,274	-30,106	-2,205	-24,792	-3,202	1,033,592	901	-3,083	-2,136	1,307	870,119	292,003	241,910	1,895	-5,263	-1,102	-4,343	3,148	4,309	-4,545	2,010	-1,563	14,696	3,858	1,482,036	3,770	-3,188	-1,732	4,716	292,953	1,001	65,515	2,080	107,053	44,147	900	2,052	3,889	-2,262	5,488	-322	6,285	-24,982	531	-137	-9,315	1,308	108	2,213	886	456,462	-6,053	3,709	3,951	603	285,582	-232	-232	-1,264	-3,446	-264	-264	96,137	-5,352	-30	-412	-996	-9,025	6,436	-6,610	1,559	11,122	53,214	-28,545	3,134	2,198	3,610	-12,319	10,773	7,917	-12,288	-477	-393	100	1,700	900
Other Cashflows From Investing Activities	0	9,309	-14,886	-14,886	-20,481	-500	1,607	9,600	-2,630	4,540	-1,974	44,907	-50,946	-17,000	8,545	993	1,230	5,305	10,540	-17,808	-14,436	-3,059	15,336	-16,361	-23,017	-20,520	-3,496	1,200	-8,800	0	0	0	-5,983	0	0	0	3,608	4,008	3,349	0	0	0	1,994	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	489	326	163	0	447	284	121	0	163	0	0	0	0	15,055	0	0	0	0	0	0	0	0	0	617	0	0	0	184	0	0	0	0	0	0	0	0
Other Non Cash Items	5,468	19,274	18,026	-825	16,071	35,292	14,493	9,777	4,550	-17,069	18,553	2,346	-99,330	4,835	3,954	22,182	7,718	155,867	-770	11,818	17,774	9,920	6,164	7,140	5,908	7,042	7,972	2,253	63,325	9,242	-1,201	4,276	-39,982	24,858	20,425	27,784	-14,949	52,714	5,987	4,141	-7,293	-22,789	49,079	-4,007	-3,084	-16,875	21,633	-2,944	49,555	-10,407	909	-3,043	-1,417	-10,621	-1,379	-672	-8,284	2,486	-623	915	-15,300	5,645	15,975	-4,262	-8,976,221	31,246	700	-326,606	-3,369	-441	3,529	4,296	4,296	1,054	2,902	-37	-37	985	11,032	640	4,976	1,959	615	830	-4,597	199	2,069	4,671	0	3,387	4,446	3,747	7,749	13,784	4,497	1	5,494	121	400	200	-200
Sale Purchase Of Stock	0	-4,659	-12,524	0	-505	-8,168	0	0	-17,695	0	0	0	-63,995	0	0	0	74,450	-56	-30,021	-44,373	-38,104	-45,799	-20,782	292	304,915	-60,970	1,113	-243,945	6,269	0	0	0	20,818	-5,826	-14,992	0	-34,977	-14,164	-34,438	-43,310	-18,965	-3,724	-2,558	-60,782	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock Based Compensation	12,033	13,059	7,860	14,148	13,656	12,602	11,166	12,083	6,970	12,124	9,609	9,688	9,715	14,717	7,825	8,679	7,895	34,788	12,410	10,800	9,503	11,337	9,167	10,106	6,750	8,634	10,153	8,905	5,250	9,158	7,962	5,918	4,990	2,545	10,285	9,745	12,585	10,190	9,268	10,145	11,190	8,288	9,860	8,597	6,412	6,317	7,419	5,208	5,218	5,076	5,294	3,951	3,634	3,650	3,727	2,581	2,395	2,349	2,815	2,188	9,791	0	0	2,178	8,982,000	-7,431	-344	326,000	0	204	-130	84	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16	-391	0	0	21	0	0	0
Total Cash From Financing Activities	-7,436	-401,091	-15,472	-9,828	-546,373	408,021	23,207	-10,658	-30,969	-75,919	-2,626	-40,852	-92,916	59,187	-25,784	9,386	-102,828	-2,153	-53,695	-480,404	427,947	-42,167	-23,179	-2,193	1,202	337,637	292,799	-244,451	5,229	-10,870	-992	-3,971	3,607	586	-80,455	-182,351	-37,693	-15,003	-30,893	276,432	-18,980	-4,833	-4,829	-40,117	145,018	3,588	66,763	11,235	-243,901	-73,881	1,643	5,509	4,316	-49,677	8,090	2,043	91,724	525,591	7,270	4,613	-3,392	5,801	2,105	8,255	12,377	482,460	-3,773	5,814	5,814	3,189	287,007	587	587	1,224	-2,327	1,007	1,007	97,415	-4,510	1,711	179	212	-8,788	6,513	-6,527	1,765	12,040	54,504	54,504	3,916	3,723	4,102	-11,791	12,575	8,897	5,159	329	566	500	2,200	900
Total Cash From Operating Activities	151,368	124,684	111,477	71,926	124,319	211,582	171,953	207,410	198,458	155,517	156,399	128,627	269,712	37,499	134,682	15,913	109,430	94,197	82,482	44,734	110,510	82,748	118,023	48,215	76,066	81,197	69,359	60,157	100,023	93,811	99,077	48,691	86,762	96,062	71,830	62,843	79,017	89,734	73,604	45,610	82,187	82,938	47,957	45,875	69,914	74,927	88,916	11,123	79,679	59,040	56,017	50,043	85,823	88,449	46,926	29,554	52,664	76,884	73,673	13,774	88,524	31,476	47,320	5,678	22,115	27,581	13,935	31,952	31,952	23,651	23,548	26,368	26,368	19,234	24,918	23,689	23,689	-8,737	26,453	12,393	18,321	26,648	14,483	4,608	8,814	13,485	5,576	20,284	20,284	5,449	19,823	12,531	25,173	-2,936	8,974	7,661	7,298	6,878	7,000	5,000	-1,600
Total Cashflows From Investing Activities	0	248,369	156,277	156,277	-133,347	-44,448	-251,537	-306,252	95,291	-219,035	-184,657	105,975	-54,502	-317,605	-84,293	13,119	-80,710	-13,217	42,245	-170,596	21,210	-112,095	-228,999	108,528	-464,264	-292,360	-67,921	-11,593	-179,056	-56,118	-125,000	17,684	-146,200	0	0	26,836	-407,601	0	0	0	-251,735	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31
Cost Of Revenue	742,387	756,955	800,837	642,536	521,162	500,888	494,975	493,338	454,611	479,839	486,494	430,432	419,938	371,869	342,752	293,285	216,227	141,168	123,194	127,112	122,404	96,508	79,673	48,966	32,130	27,000	15,100	12,200	7,700
Depreciation And Amortization	205,336	292,663	292,919	209,971	231,458	206,436	216,448	213,056	191,473	37,070	35,495	36,117	26,746	23,492	120,394	105,704	62,583	30,038	24,955	22,961	25,788	24,709	15,059	10,455	7,831	5,800	4,900	2,500	1,800
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	445,247	531,460	630,084	554,901	336,218	293,030	164,060	95,930	169,894	157,844	68,220	168,605	105,716	192,994	183,727	174,728	176,308	120,252	105,777	101,522	71,409	72,081	53,060	55,271	30,194	12,100	4,000	3,800	4,200
Ebitda	650,583	824,123	923,003	764,872	567,676	499,466	380,508	308,986	361,367	194,914	103,715	204,722	132,462	216,486	304,121	280,432	238,891	150,290	130,732	124,483	97,197	96,790	68,119	65,726	38,025	17,900	8,900	6,300	6,000
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	60,800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	1,222,924	1,384,563	1,450,820	1,227,810	1,005,262	1,000,960	922,561	844,653	826,375	864,938	815,490	824,024	749,809	715,562	667,073	599,690	433,547	324,610	275,201	253,517	229,000	202,099	184,097	155,065	111,830	83,200	59,200	42,000	29,300
Income Before Tax	429,809	512,601	625,833	154,927	-77,776	225,737	114,375	56,908	132,498	118,514	37,338	145,153	96,212	173,121	172,330	119,286	75,726	106,068	97,264	72,687	67,255	38,865	56,315	37,073	22,964	17,500	13,600	8,600	4,500
Income Tax Expense	88,506	89,390	113,234	81,287	-36,321	35,357	73,981	-23,395	5,641	1,312	-31,760	15,616	1,263	28,810	34,563	29,762	25,555	35,529	35,039	23,982	24,405	15,723	21,896	16,967	10,347	5,100	4,800	3,300	2,100
Interest Expense	53,410	58,357	54,477	73,002	74,185	67,293	49,685	39,022	37,396	39,330	30,882	23,452	25,358	27,815	29,641	37,527	31,455,000	11,918,000	5,940,000	5,101,000	4,647,000	2,565,000	0	0	0	0	0	0	0
Interest Income	75,993	32,757	9,555	10,032	22,113	20,851	10,645	6,776	9,689	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	2,034	568	25	31	0	0	0	491	49	0	0	0	0	0	8	36	0	0	0	0	0
Net Income	341,303	423,211	512,599	73,640	-41,455	190,380	40,394	80,404	127,103	116,634	69,073	129,506	96,038	144,311	137,767	89,033	50,122	70,539	62,225	48,705	42,850	23,142	34,419	20,106	12,617	12,400	8,800	5,300	2,400
Net Income Applicable To Common Shares	0	575,661	512,599	359,188	-41,455	190,380	40,394	80,404	130,148	116,634	69,073	129,506	96,038	144,311	137,767	89,033	50,122	70,539	62,225	48,705	42,850	23,142	34,419	20,106	0	0	0	0	0
Net Income From Continuing Ops	332,483	423,211	512,599	359,188	-41,455	190,380	40,394	80,303	129,902	116,933	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	20,149	-25,600	-44,922	-61,285	-52,072	-46,442	-39,040	-32,246	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	445,247	531,460	630,084	554,901	336,218	266,581	153,419	98,827	175,693	160,818	63,330	169,814	99,588	188,537	180,205	145,662	83,133	100,601	94,837	84,140	68,889	43,185	53,476	34,872	26,467	14,600	8,300	6,000	4,700
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	1,520,064	1,565,290	1,593,811	1,325,477	1,212,751	1,235,267	1,264,117	1,239,164	1,105,293	1,183,959	1,238,654	1,084,642	1,070,159	898,894	829,620	731,960	517,784	355,464	297,106	292,100	279,467	241,801	210,294	153,351	117,493	95,600	66,000	48,200	32,300
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	208,438	208,397	214,931	205,014	231,458	206,436	216,448	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Research Development	198,511	189,859	189,964	139,060	157,448	161,852	154,084	176,135	147,180	163,627	146,070	122,476	130,636	126,040	107,900	97,331	64,935	41,560	39,100	34,159	31,789	28,177	26,769	22,212	16,271	12,800	8,300	6,500	4,400
Selling And Marketing Expenses	459,912	474,220	456,392	434,158	391,906	392,281	375,562	401,352	360,962	376,873	371,523	343,549	307,332	267,484	244,814	227,408	164,690,000	115,942,000	94,689,000	87,506,000	83,005,000	75,086,000	0	0	0	0	0	0	0
Selling General Administrative	119,254	129,725	128,076	110,153	112,262	141,214	200,098	129,248	103,874	126,550	199,072	152,068	185,507	110,009	115,933	341,344	236,622	164,516	134,812	129,221	125,274	117,116	100,852	82,173	61,261	50,000	0	0	0
Tax Provision	84,287	89,390	113,234	80,284	-36,321	35,357	73,981	-23,395	6,401	1,312	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	777,677	808,335	792,974	682,941	691,589	734,379	769,142	745,826	650,682	704,120	752,160	654,210	650,221	527,025	486,868	438,675	301,557	214,296	173,912	164,988	157,063	145,293	130,621	104,385	85,363	68,600	50,900	36,000	24,600
Total Other Income Expense Net	-15,438	-18,859	-4,251	-399,974	-413,994	5,598	-4	-9,673	-10,552	-6,938	2,591	-3,591	15,854	7,942	18,244	-13,713	-44,318	-8,687	-5,637	-15,236	-1,319	-16,615	-957	-4,591	-3,727	2,500	4,300	2,200	500
Total Revenue	1,965,311	2,141,518	2,251,657	1,870,346	1,526,424	1,501,848	1,417,536	1,337,991	1,280,986	1,344,777	1,301,984	1,254,456	1,169,747	1,087,431	1,009,825	892,975	649,774	465,778	398,395	380,629	351,404	298,607	263,770	204,031	143,960	110,200	74,300	54,200	37,000

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31
Cost Of Revenue	164,018	177,934	182,705	177,922	180,460	178,580	184,494	213,421	208,574	197,528	198,120	196,615	197,801	162,989	148,282	128,559	133,907	127,744	135,697	123,814	138,419	121,135	123,440	117,894	135,584	123,096	124,433	111,861	138,507	117,879	123,514	113,631	125,223	109,915	118,916	100,557	144,632	113,283	114,968	106,955	125,222	111,411	146,297	103,563	114,009	105,132	104,239	107,052	132,701	101,353	93,768	92,117	97,008	93,797	89,912	91,152	100,965	86,647	80,656	74,484	79,730	77,861	69,812	65,882	71,427	60,444	41,577	37,740	37,740	36,167	33,916	29,520	29,520	30,007	32,811	31,284	31,284	30,702	32,494	32,632	35,307	31,389	30,162	25,546	24,655	26,453	24,355	22,140	22,140	19,970	20,272	17,291	12,623	12,558	12,133	9,435	9,176	6,487	8,500	7,900	2,800	8,200	8,100	6,800	600	5,100	4,600	4,900	-	-	-	2,800
Depreciation And Amortization	51,570	50,569	51,136	52,061	30,160	50,317	62,184	60,972	3,345	53,161	55,082	55,587	5,432	50,828	48,540	48,476	5,827	56,869	62,365	59,260	9,436	48,855	54,695	52,914	10,022	52,280	56,595	54,753	9,704	53,406	52,485	50,804	9,777	49,479	44,061	46,126	9,091	51,317	49,244	49,122	9,387	50,431	49,580	45,085	8,902	50,141	48,202	45,233	46,779	42,957	38,950	38,691	38,404	35,594	34,840	33,941	33,811	30,374	4,011	27,366	26,975	28,052	25,247	25,430	24,675	19,784	9,388	8,073	8,073	7,902	7,343	6,169	6,169	6,286	6,482	4,836	4,836	5,169	6,060	6,896	6,846	6,533	6,542	5,867	6,664	6,357	7,108	3,669	3,669	4,077	3,747	3,566	3,388	2,111	2,676	2,280	1,898	2,033	2,000	1,900	-500	-500	-700	-700	-1,200	-1,000	-1,000	-1,100	-	-	-	600
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Ebit	134,490	122,869	124,415	129,052	104,573	138,221	122,157	207,071	180,786	144,524	172,399	171,805	286,064	150,754	147,388	77,621	123,421	78,898	70,050	48,848	88,616	88,458	61,793	54,163	50,790	63,653	22,972	26,644	-3,338	46,256	32,000	18,233	56,160	46,770	38,703	28,259	23,981	48,312	49,710	35,841	38,792	37,829	-38,847	30,446	46,877	39,565	46,009	37,072	-18,421	36,632	47,789	39,716	51,813	51,462	44,351	45,370	43,921	54,032	47,560	38,214	-8,452	68,559	52,419	179,671	45,517	63,999	32,734	35,301	30,547	29,599	23,102	35,145	35,145	25,657	26,794	24,210	24,210	22,034	36,508	18,770	18,092	18,255	16,381	18,681	27,007	13,228	16,120	14,693	17,127	10,296	13,039	14,932	21,453	10,570	15,888	6,732	12,078	6,815	6,100	5,300	3,400	4,500	3,400	3,700	2,000	2,200	2,000	2,000	-	-	-	1,700
Ebitda	186,060	173,438	175,551	181,113	134,733	188,538	184,341	268,043	184,131	197,685	227,481	227,392	291,496	201,582	195,928	126,097	129,248	135,767	132,415	108,108	98,052	137,313	116,488	107,077	60,812	115,933	79,567	81,397	6,366	99,662	84,485	69,037	65,937	96,249	82,764	74,385	33,072	99,629	98,954	84,963	48,179	88,260	10,733	75,531	55,779	89,706	94,211	82,305	28,358	79,589	86,739	78,407	90,217	87,056	79,191	79,311	77,732	84,406	51,571	65,580	18,523	96,611	77,666	205,101	70,192	83,783	42,122	43,374	38,620	37,501	30,445	41,314	41,314	31,943	33,276	29,046	29,046	27,203	42,568	25,666	24,938	24,788	22,923	24,548	33,671	19,585	23,228	18,362	20,796	14,373	16,786	18,498	24,841	12,681	18,564	9,012	13,976	8,848	8,100	7,200	2,900	4,000	2,700	3,000	800	1,200	1,000	900	-33,200	14,200	12,600	2,300
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Gross Profit	345,144	297,960	312,152	307,476	317,524	321,051	331,018	414,970	373,824	337,217	369,188	370,591	373,433	320,774	294,970	243,538	279,565	254,942	245,915	224,840	264,754	256,776	253,756	225,674	261,279	240,881	224,557	195,845	228,008	220,806	210,898	184,748	223,317	204,646	200,540	197,872	215,778	223,174	215,869	210,118	235,863	210,700	168,915	200,013	232,522	199,157	202,974	189,370	201,719	187,532	188,409	172,148	189,024	180,520	172,806	173,212	188,112	173,012	159,500	146,449	157,451	152,939	148,076	141,224	138,797	116,188	93,462	88,151	88,151	81,772	79,317	74,825	74,825	68,664	67,543	64,247	64,247	59,701	66,143	63,426	59,814	59,057	56,089	54,040	53,793	50,429	48,392	49,093	49,093	43,373	45,775	45,856	44,084	37,947	37,673	32,799	29,952	29,154	26,700	26,100	27,300	20,100	18,100	17,200	19,700	13,900	13,300	12,200	15,000	14,200	12,600	9,700
Income Before Tax	118,876	99,830	102,316	108,787	105,837	95,718	115,524	195,522	165,379	151,455	149,899	159,100	256,487	27,904	108,752	46,329	68,939	-226,997	51,824	28,458	68,433	72,203	45,958	39,143	33,848	51,653	12,391	16,483	-13,991	36,630	22,592	8,897	46,511	37,564	29,374	19,048	14,016	37,474	39,185	27,839	30,876	30,336	-46,654	22,781	38,547	34,041	39,428	33,137	-22,051	43,005	39,970	35,287	45,374	46,856	39,540	41,351	49,411	49,319	41,036	32,564	36,173	27,846	27,572	27,694	20,155	-5,955	32,509	27,824	27,824	28,276	23,390	26,518	26,518	26,675	22,378	22,441	22,441	20,327	11,712	18,207	15,675	19,023	17,101	15,456	3,984	11,989	7,888	18,321	18,321	9,899	16,823	11,272	11,527	10,982	5,643	8,359	3,040	7,710	6,300	5,900	4,100	5,000	4,300	4,700	3,500	3,400	3,200	3,400	-	-	-	2,000
Income Tax Expense	21,212	22,012	21,530	23,752	16,993	13,324	18,863	40,210	36,193	18,316	28,848	29,877	43,802	10,994	18,988	6,500	24,007	-66,362	7,096	-1,062	7,483	11,883	9,143	6,848	73,541	3,168	-1,560	-1,168	-22,614	2,922	1,591	-5,939	-1,862	3,550	4,268	-316	-12,033	2,660	6,130	4,556	-29,111	-10,440	5,083	2,708	263	4,960	5,745	4,647	-21,264	8,538	6,682	7,306	9,085	10,368	1,020	8,337	4,947	11,629	10,107	7,880	11,490	6,679	4,291	7,301	5,099	1,380	9,926	8,377	8,377	8,918	9,236	9,658	9,658	9,035	8,601	6,599	6,599	7,687	2,910	6,786	6,688	7,258	5,998	4,461	2,211	4,700	3,314	7,387	7,387	3,706	5,488	5,315	4,943	4,485	4,216	3,136	2,682	3,230	2,300	2,100	400	1,800	1,400	1,800	600	1,400	1,300	1,400	-1,800	-1,500	-1,100	1,000
Interest Expense	12,441	13,018	13,497	14,454	14,875	16,287	13,659	13,536	12,456	14,576	13,907	13,538	16,903	18,052	17,440	18,922	18,321	17,248	18,226	20,390	20,183	16,255	15,835	15,020	16,942	12,000	10,581	10,161	10,653	9,626	9,408	9,336	9,649	9,206	9,329	9,211	9,965	10,838	10,525	8,002	7,916	7,493	7,807	7,665	8,330	4,967	5,137	5,017	5,877	6,537	6,636	6,307	6,912	6,980	7,669	6,254	7,505	7,405	7,302	7,431	8,695	9,194	9,187	10,451	31,455,000	10,742	4,923	11,918,000	3,980	7,558	1,934	5,940,000	5,940,000	1,521	1,533	5,101,000	5,101,000	1,653	970	1,022	4,647,000	972	1,066	1,044	2,565,000	577	520	651	87	213	171	520	427	435	375	385	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Interest Income	19,261	20,380	21,343	18,008	16,262	9,935	4,338	2,222	2,581	3,263	2,093	1,618	1,636	1,715	3,497	3,184	4,197	4,665	5,163	12,307	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,950	84	0	0	206	125	221	16	-50	75	24	90	31	-350	350	0	0	0	0	0	0	0	0	0	0	0	0	0	115	376	56	60	56	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	0	-8	8	-37	73	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Net Income	97,664	77,818	80,786	85,035	88,844	82,394	96,661	155,312	129,186	133,139	121,051	129,223	212,685	16,910	89,764	39,829	44,932	-160,635	44,728	29,520	60,950	60,320	36,815	32,295	-39,693	48,485	13,951	17,651	8,623	33,761	21,001	14,883	48,573	33,930	25,110	19,490	25,843	34,689	32,834	23,267	60,150	40,701	-51,761	19,983	38,419	29,163	33,333	28,592	-376	35,145	33,288	27,981	36,289	36,488	38,520	33,014	44,464	37,690	30,929	24,684	24,683	20,791	23,225	20,333	15,000	-7,328	22,583	19,447	19,447	19,358	14,154	16,860	16,860	17,640	13,777	15,842	15,842	12,640	8,802	11,421	8,987	11,765	11,103	10,995	1,773	7,289	4,574	10,934	10,934	6,193	11,335	5,957	6,584	6,497	1,427	5,223	358	4,480	4,000	3,800	3,700	3,200	2,900	2,900	2,900	2,000	1,900	2,000	1,800	1,500	1,100	1,000
Net Income Applicable To Common Shares	0	77,818	80,786	80,786	241,294	82,394	96,661	155,312	129,186	133,139	121,051	129,223	212,685	16,910	89,764	39,829	44,933	-160,635	44,728	29,520	60,950	60,320	36,815	32,295	-8,091	48,485	13,951	17,651	8,623	34,804	21,266	15,711	48,573	33,930	25,110	19,490	25,843	34,689	32,835	23,267	60,150	40,701	-19,983	19,983	38,419	29,163	33,332	28,592	60,891	35,147	33,288	27,981	36,289	36,489	38,519	33,014	44,464	37,690	30,929	24,684	24,683	20,791	23,226	20,333	15,000	-22,583	22,583	19,867	19,447	19,358	14,154	17,580	16,860	17,640	13,777	13,948	15,842	12,640	8,802	11,421	8,987	11,765	11,103	10,995	1,773	7,289	4,574	9,506	10,934	6,193	11,335	5,957	6,344	7,155	1,865	5,639	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Net Income From Continuing Ops	97,664	77,818	80,786	85,035	88,844	82,394	96,661	155,312	129,186	133,139	121,051	129,223	212,685	16,910	89,764	39,829	44,933	-160,635	44,728	29,520	60,950	60,320	36,815	32,295	-72,144	169,191	-74,304	17,651	80,303	0	0	0	129,902	0	0	0	116,933	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Net Interest Income	6,820	7,362	7,846	3,554	1,387	-6,352	-9,321	-11,314	-9,875	-11,313	-11,814	-11,920	-15,267	-16,337	-13,943	-15,738	-14,124	-12,583	-13,063	-12,302	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Non Operating Income Net Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Operating Income	134,490	97,181	105,432	129,052	104,573	138,221	122,157	207,071	173,141	131,874	-161,271	163,798	155,914	44,508	118,695	67,314	79,989	-207,453	60,176	41,152	88,273	77,033	53,333	47,942	43,372	63,931	22,365	23,751	4,193	46,972	29,481	15,401	54,403	46,171	39,987	35,131	20,569	50,254	47,692	42,303	34,008	34,412	-34,161	29,071	48,925	38,978	45,427	36,483	-19,610	34,297	46,455	38,445	50,772	50,235	42,850	44,681	42,940	53,354	46,882	37,029	40,436	38,178	34,011	33,038	25,011	-1,711	31,037	26,898	30,547	26,743	21,715	25,971	25,971	25,875	21,598	22,255	22,255	20,904	22,890	18,091	16,168	19,310	17,319	16,092	5,176	12,945	9,352	17,127	17,127	10,081	14,753	11,515	5,669	10,581	10,590	7,403	7,461	7,208	6,200	5,700	3,400	4,500	3,400	3,700	2,000	2,200	2,000	2,000	-33,200	14,200	12,600	1,900
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Other Operating Expenses	374,672	368,692	380,823	382,877	385,359	375,756	388,607	415,568	406,306	393,484	397,002	397,019	402,646	334,457	303,361	292,413	297,322	301,492	321,436	307,502	314,900	300,878	323,863	295,626	353,491	300,046	326,625	283,955	362,322	291,713	304,931	282,978	294,137	268,390	279,469	263,298	339,841	286,203	283,145	274,770	327,077	287,699	349,373	274,505	297,606	265,311	261,786	259,939	354,030	254,588	235,722	225,820	235,260	224,082	219,868	219,683	246,137	206,305	193,274	183,904	220,033	179,048	174,461	34,485	173,673	144,946	102,586	95,344	95,344	89,747	90,633	72,661	72,661	72,771	75,480	72,396	72,396	68,736	73,942	77,026	77,472	71,136	68,932	61,927	62,499	63,937	60,547	54,106	54,106	53,362	51,294	51,632	35,230	39,924	39,216	34,831	31,667	28,433	29,000	28,300	26,700	23,800	22,800	20,300	18,300	16,800	15,900	15,100	48,200	-	-	10,600
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Reconciled Depreciation	51,570	50,569	51,136	52,061	54,672	50,317	50,410	52,998	51,101	53,161	55,082	55,587	57,170	50,828	48,540	48,476	52,964	56,869	62,365	59,260	49,972	48,855	54,695	52,914	52,820	52,280	56,595	54,753	56,361	53,406	52,485	50,804	51,807	49,479	44,061	46,126	51,099	51,317	49,244	49,122	54,259	50,431	49,580	45,085	54,316	50,141	48,202	45,233	46,779	42,957	38,950	38,691	38,404	35,594	34,840	33,941	33,811	30,374	28,843	27,366	26,975	28,052	25,247	25,430	24,675	19,784	9,388	8,073	8,073	7,902	7,343	6,720	6,169	6,286	6,482	6,018	4,836	5,169	6,060	6,896	6,846	6,533	6,542	5,867	6,664	6,357	7,108	3,669	3,669	4,077	3,747	3,566	3,388	2,111	2,676	2,280	1,898	2,033	2,000	1,900	-	-	-	-	-	-	-	-	-	-	-	600
Research Development	45,966	47,934	49,893	54,718	44,719	48,868	49,896	46,376	42,113	48,268	52,150	47,433	46,345	36,097	31,818	34,813	33,988	41,845	40,827	40,788	40,667	42,030	39,633	39,522	40,944	38,429	38,787	37,830	58,511	36,202	42,120	39,759	39,710	35,568	33,575	38,328	43,920	41,461	37,909	40,336	43,792	34,340	33,639	34,300	32,211	31,008	30,621	28,637	32,814	32,646	32,508	32,667	34,039	30,980	29,423	31,597	30,560	26,747	24,950	25,643	28,050	24,073	23,840	21,369	22,844	17,870	12,690	11,012	11,012	10,125	10,235	10,749	10,749	8,877	9,421	7,889	7,889	7,641	9,257	9,372	9,119	7,538	7,622	7,510	7,688	7,310	6,743	6,944	6,944	6,125	7,038	6,662	5,935	5,419	5,675	4,312	4,791	3,787	4,000	3,700	3,700	3,300	2,900	2,600	2,300	2,000	2,100	1,900	-	-	-	1,300
Selling And Marketing Expenses	117,478	111,462	116,331	114,641	122,244	114,582	118,890	118,504	119,383	112,855	110,394	113,760	121,375	102,176	94,376	95,757	98,316	97,018	100,686	95,886	97,876	96,473	101,853	96,079	92,227	96,641	103,867	92,338	115,005	94,442	98,771	93,973	93,763	88,759	89,830	88,611	100,595	92,087	92,817	91,373	98,492	92,158	91,296	89,577	91,009	84,892	85,269	82,379	82,319	80,143	76,455	68,414	69,852	66,941	66,255	64,436	68,957	60,719	59,039	56,098	59,662	55,972	57,696	54,078	164,690,000	45,162	31,995	115,942,000	0	28,707	28,762	94,689,000	94,689,000	24,066	23,495	87,506,000	87,506,000	20,030	21,402	23,603	83,005,000	20,784	20,636	19,189	75,086,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Selling General Administrative	28,474	28,649	29,192	32,939	31,967	30,880	32,528	34,350	32,891	30,364	31,018	33,803	31,693	27,928	23,863	28,194	25,284	28,752	35,539	37,688	28,502	31,875	48,886	31,951	74,714	31,863	49,857	32,248	40,595	33,339	30,787	25,818	25,664	24,562	27,481	26,167	41,603	30,054	28,104	26,791	50,184	40,795	69,132	38,962	51,475	34,717	31,967	33,908	98,591	33,705	26,815	26,397	28,747	26,484	28,438	26,340	39,723	27,805	24,618	23,788	112,253	77,114	77,993	73,981	79,402	66,632	45,661	44,129	44,129	41,096	44,589	34,722	34,722	33,613	33,501	32,187	32,187	29,821	32,191	35,022	33,046	32,209	31,148	28,871	30,156	30,174	29,449	25,022	25,022	27,167	23,984	24,679	23,739	19,836	18,732	18,804	0	0	14,500	14,800	-	-	-	-	-	-	-	-	-	-	-	0
Tax Provision	21,212	22,012	21,530	23,752	16,993	13,324	18,863	40,210	36,193	18,316	28,848	29,877	43,802	10,994	18,988	6,500	24,007	-66,362	7,096	-1,062	7,483	11,883	9,143	6,848	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Total Operating Expenses	210,654	190,758	198,118	204,955	204,899	197,176	204,113	202,147	197,732	195,956	198,882	200,404	204,845	171,468	155,079	163,854	163,415	173,748	185,739	183,688	176,481	179,743	200,423	177,732	217,907	176,950	202,192	172,094	223,815	173,834	181,417	169,347	168,914	158,475	160,553	162,741	195,209	172,920	168,177	167,815	201,855	176,288	203,076	170,942	183,597	160,179	157,547	152,887	221,329	153,235	141,954	133,703	138,252	130,285	129,956	128,531	145,172	119,658	112,618	109,420	140,303	101,187	104,649	-31,397	102,246	84,502	61,009	57,604	57,604	53,580	56,717	43,141	43,141	42,764	42,669	41,112	41,112	38,034	41,448	44,394	42,165	39,747	38,770	36,381	37,844	37,484	36,192	31,966	31,966	33,392	31,022	34,341	22,607	27,366	27,083	25,396	22,491	21,946	20,500	20,400	23,900	15,600	14,700	13,500	17,700	11,700	11,300	10,200	-48,200	-	-	7,800
Total Other Income Expense Net	-15,614	-14,734	-19,564	-20,265	1,264	-42,503	-6,633	-11,549	-838	21,507	-8,593	833	103,166	-105,065	-17,196	-17,617	-33,087	-295,608	4,711	-392	-5,421	6,116	3,356	1,547	3,071	-2,948	-1,111	983	-9,632	-2,374	1,017	1,316	32	-684	-2,330	-7,571	2,224	-2,878	1,187	-7,472	4,307	2,867	-5,099	517	-2,672	-557	-1,444	1,082	2,247	12,910	-1,183	1,878	473	2,374	2,858	2,235	12,995	2,692	778	1,781	25,600	-16,807	-8,992	-7,050	-8,966	-32,313	-281	-4,302	-4,302	-1,187	-249	-3,465	-3,465	240	-2,569	-1,372	-1,372	-1,120	-12,509	-235	-1,026	458	628	-1,379	-11,554	-550	-4,116	1,061	1,061	-315	1,714	-3,417	24	11	-5,298	671	-4,617	393	100	400	500	500	700	700	1,200	1,000	1,000	1,100	-	-	-	200
Total Revenue	509,162	475,894	494,857	485,398	497,984	499,631	515,512	628,391	582,398	534,745	567,308	567,206	571,234	483,763	443,252	372,097	413,472	382,686	381,612	348,654	403,173	377,911	377,196	343,568	396,863	363,977	348,990	307,706	366,515	338,685	334,412	298,379	348,540	314,561	319,456	298,429	360,410	336,457	330,837	317,073	361,085	322,111	315,212	303,576	346,531	304,289	307,213	296,422	334,420	288,885	282,177	264,265	286,032	274,317	262,718	264,364	289,077	259,659	240,156	220,933	237,181	230,800	217,888	207,106	210,224	176,632	135,039	125,891	125,891	117,939	113,233	104,345	104,345	98,671	100,354	95,531	95,531	90,403	98,637	96,058	95,121	90,446	86,251	79,586	78,448	76,882	72,747	71,233	71,233	63,343	66,047	63,147	56,707	50,505	49,806	42,234	39,128	35,641	35,200	34,000	30,100	28,300	26,200	24,000	20,300	19,000	17,900	17,100	15,000	14,200	12,600	12,500

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	1,965,311
Cost of Revenue	-742,387
Gross Profit	1,222,924	1,222,924

Operating Income (+$)
Gross Profit	1,222,924
Operating Expense	-777,677
Operating Income	445,247	445,247

Operating Expense (+$)
Research Development	198,511
Selling General Administrative	119,254
Selling And Marketing Expenses	459,912
Operating Expense	777,677	777,677

Net Interest Income (+$)
Interest Income	75,993
Interest Expense	-53,410
Other Finance Cost	-2,434
Net Interest Income	20,149

Pretax Income (+$)
Operating Income	445,247
Net Interest Income	20,149
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	429,809	460,685 EBIT - interestExpense = 391,837 429,809 394,713
Interest Expense	53,410
Earnings Before Interest and Taxes (EBIT)	445,247	483,219
Earnings Before Interest and Taxes (EBITDA)	650,583

After tax Income (+$)
Income Before Tax	429,809
Tax Provision	-84,287
Net Income From Continuing Ops	332,483	345,522
Net Income	341,303
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	1,520,064
Total Other Income/Expenses Net	-15,438	-20,149

Technical Analysis of Qiagen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Qiagen. The general trend of Qiagen is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Qiagen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (-42.9%)		Bearish trend (42.9%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of Qiagen NV.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 44.97 < 45.07 < 45.38.

The bearish price targets are: 39.23 > 38.08 > 35.58.

Tweet this

Qiagen NV Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Qiagen NV. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

MA 20 trending down: The MA 20 is trending down. -1
Close > MA 20: The price is above the MA 20. +1
MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
MA 50 trending down: The MA 50 is trending down. -1
Close < MA 50: The price is below the MA 50. -1
MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
MA 100 trending up: The MA 100 is trending up. +1
Close < MA 100: The price is below the MA 100. -1
MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
MA 200 trending down: The MA 200 is trending down. -1
Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Qiagen NV. The current macd is -0.7186151.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Qiagen price going up in the near term. +2
MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Qiagen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Qiagen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1

Qiagen NV Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of Qiagen NV. The current adx is 26.70.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Qiagen shares, leading to potential upward momentum in its price. +1
PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2

Qiagen NV Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Qiagen NV. The current sar is 39.08.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Qiagen NV. The current rsi is 52.85. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Trending up: The RSI is trending up. +1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

Qiagen NV Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Qiagen NV. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
STOCH > 80: The STOCH %K is above 80 and overbought. +2
STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Qiagen price going up in the near term. +2
Trending up: The STOCH %K is trending up. +1

Qiagen NV Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Qiagen NV. The current cci is 34.78.

Qiagen NV Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Qiagen NV. The current cmo is 20.93.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1

Qiagen NV Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of Qiagen NV. The current willr is -3.05084746.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of Qiagen NV.

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Qiagen NV. The current atr is 0.72085255.

Qiagen NV Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Qiagen NV. The current obv is 3,275,741.

Qiagen NV Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Qiagen NV. The current mfi is 54.38.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

MFI > 50: +1

Qiagen NV Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for Qiagen NV.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-11-30	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-04	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-07	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2023-12-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-11	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2023-12-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-13	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-14	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-15	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2023-12-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2023-12-20	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2023-12-21	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-22	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-29	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-02	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-03	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-04	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-01-05	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-01-08	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-01-09	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-16	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-17	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-23	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-01-24	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-26	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-31	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-01	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-02	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-02-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-06	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-07	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-09	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-02-13	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-02-14	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-02-15	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-16	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-21	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-22	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-27	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-28	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-01	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-04	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-05	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-03-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-11	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-03-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-19	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-20	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-03-21	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-25	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-03-26	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-01	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-03	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-04	STOCH	LONG EXIT		The %K line crosses below the %D line.
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-08	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-10	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-12	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-15	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-04-16	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-17	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-19	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
2024-04-22	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-04-23	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside

6.3. Candlestick Patterns

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of Qiagen NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	52.853
Ma 20	Greater than	Ma 50	41.207
Ma 50	Greater than	Ma 100	42.687
Ma 100	Greater than	Ma 200	43.045
Open	Greater than	Close	41.280
Total			2/5 (40.0%)

Create your own Symbol Scanner

Get notifications about Qiagen NV

I send you an email if I find something interesting about Qiagen NV.

Qiagen NV Buy, Hold or Sell?

Let's analyse Qiagen together

Get notifications about Qiagen NV

Quick analysis of Qiagen (30 sec.)

What can you expect buying and holding a share of Qiagen? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Qiagen (5 min.)

$41.89

$17.01

$-11.45 - $20.74

$5.56 - $37.75

2. Growth of Qiagen (5 min.)

Is Qiagen growing?

How much money is Qiagen making?

How much money comes from the company's main activities?

3. Financial Health of Qiagen (5 min.)

4. Comparing to competitors in the Diagnostics & Research industry (5 min.)

Industry Rankings (Diagnostics & Research)

What can you expect buying and holding a share of Qiagen? (5 min.)

What can you expect buying and holding a share of Qiagen?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Qiagen

About Qiagen NV

Financial Health

Valuation

1.1. Profitability of Qiagen NV.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Diagnostics & Research)

1.1.2. Return on Assets

Trends

Compared to industry (Diagnostics & Research)

1.1.3. Return on Equity

Trends

Compared to industry (Diagnostics & Research)

1.2. Operating Efficiency of Qiagen NV.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Diagnostics & Research)

1.2.2. Operating Ratio

Trends

Compared to industry (Diagnostics & Research)

1.3. Liquidity of Qiagen NV.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Diagnostics & Research)

1.3.2. Quick Ratio

Trends

Compared to industry (Diagnostics & Research)

1.4. Solvency of Qiagen NV.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Diagnostics & Research)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Diagnostics & Research)

2. Market Valuation of Qiagen NV

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Diagnostics & Research)

Qiagen NV
Buy, Hold or Sell?